Programme: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Room 1 - Main Arena 1

21 events

Tuesday, January 22nd: 8:00 - 9:30, Room 1 - Main Arena 1

Symposium: Keep on walking: Steps towards successfull PAD treatment

supported with an educational grant from Abbott Vascular

Moderator:

Dierk Scheinert

Panel:

Thomas Zeller, Jonathan Sobocinski, Koen Deloose, Jörg Teßarek, Shannon Thomas
1. 08:00 - 08:07
  
  Step by step SFA/pop treatment algorithm
2. 08:07 - 08:14
  
  Step by step selection algorithm and clinical decision making through OCT technology
3. 08:14 - 08:45
  
  Live case transmission from Leipzig
4. 08:45 - 08:52
  
  Supera CFA VMI 1-year follow-up results
5. 08:52 - 08:59
  
  Supera in AVF management and 1-year outcomes
6. 08:59 - 09:06
  
  Supera in popliteal aneurysm, proof of concept, and clinical outcomes
7. 09:06 - 09:30
  
  Live case transmission from Leipzig
Tuesday, January 22nd: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: See clearly, treat optimally: image guided therapy on the rise

supported with an educational grant from Philips

Moderator:

Dierk Scheinert, Frans Moll

Panel:

Constantino Peña, Jim A. Reekers, Fabrizio Fanelli, Maria Louisa Izamis
1. 09:30 - 09:35
  
  Introduction and learning objectives
2. 09:35 - 09:49
  
  Next generation pan-vascular suite: optimizing patient management and outcomes
3. 09:49 - 09:57
  
  Perfusion angiography for optimizing planning and treatment of diabetic foot
4. 09:57 - 10:17
  
  BTK recorded case presentation
5. 10:17 - 10:25
  
  Role of IVUS within a “treat optimally” algorithm of care
6. 10:25 - 10:35
  
  Innovations at the forefront: a glance at the future of image guided therapy
7. 10:35 - 10:55
  
  Live case transmission from Leipzig
8. 10:55 - 11:00
  
  Q&A and conclusion
Tuesday, January 22nd: 11:00 - 12:15, Room 1 - Main Arena 1

Long-term safety of drug-eluting technologies in the leg – recent findings, controversies, and future outlook

Moderator:

Dierk Scheinert, John Laird

Panel:

Konstantinos Katsanos, Peter Schneider, Michael Dake, Thomas Zeller, William Gray, Sean Lyden
1. 11:00 - 11:10
  
  Risk of death following application of Paclitaxel-coated balloons and stents in the femoropopliteal artery – findings from a metaanalysis of RCTs
2. 11:10 - 11:16
  
  A look into the methods: merits and limits of meta-analysis
3. 11:16 - 11:22
  
  Toxicological aspects and safety profile of Paclitaxel
4. 11:22 - 11:28
  
  Event adjudication in clinical trials: how does it work?
5. PATIENT LEVEL DATA FROM MAJOR CLINICAL TRIAL PROGRAMMES WITH DRUG-ELUTING DEVICES
6. 11:28 - 11:33
  
  DCBs over the long-term: Are they safe for our PAD patients? Insights from the In.Pact DCB programme
7. 11:33 - 11:38
  
  Long-term safety data of the Lutonix DCB formulation
8. 11:38 - 11:43
  
  Long-term safety data from the Stellarex DCB programme
9. 11:43 - 11:48
  
  Long-term safety information on Paclitaxel eluting stents – insights from the Zilver PTX programme
10. 11:48 - 11:53
  
  Patient safety in the Eluvia-DES and Ranger DCB programme
11. 11:53 - 12:00
  
  How to proceed to generate more evidence on patient safety with drug-eluting devices
12. 12:00 - 12:15
  
  Podium discussion
Tuesday, January 22nd: 12:15 - 13:30, Room 1 - Main Arena 1

“To stent or not to stent?” – Latest data on stentless and stent-based treatment approaches for femoropopliteal lesions

Moderator:

Dierk Scheinert, William Gray

Panel:

Osamu Iida, Gunnar Tepe, Hiroyoshi Yokoi
1. FOCUS ON NEW DATA ON DRUG-COATED BALLOONS
2. 12:15 - 12:20
  
  First time data release: Randomized trial of DCB vs. PTA: Final 3-year clinical outcomes from IN.PACT Japan
3. 12:20 - 12:25
  
  First time data release: Insights from the IN.PACT global study 3-year data: Does lesion complexity affect results?
4. 12:25 - 12:30
  
  First time data release: Global diabetic analyses of all Lutonix DCB SFA combined trials
5. 12:30 - 12:35
  
  First time data release: COMPARE-Pilot RCT: 2-year results of a randomized comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions
6. 12:35 - 12:40
  
  First time data release: IN.PACT Global study 3-year outcomes for stented vs. non-stented lesions
7. 12:40 - 12:45
  
  First time data release: Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries: 24-months results of the BIOLUX P-III full cohort
8. 12:45 - 12:50
  
  DCB in severe Calcium: Core-laboratory analysis and perspectives from the ILLUMENATE trial series
9. 12:50 - 12:55
  
  Stellarex in real world: Interim look from the SAVER registry
10. FOCUS ON NEW DATA ON DRUG-ELUTING STENTS AND DCB/IMPLANT COMBINATIONS
11. 12:55 - 13:00
  
  First time data release: Final 12-months results of the Zilverpass-RCT of Zilver PTX vs. bypass
12. 13:00 - 13:05
  
  TOBA II Trial (Lutonix or POBA + Tack) – 1-year results
13. 13:05 - 13:10
  
  First time data release: Diabetic patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents
14. 13:10 - 13:15
  
  First time data release: Japanese patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents
15. 13:15 - 13:20
  
  First time data release: Zilver PTX Japan 5-year results for paclitaxel-eluting stent treatment of femoropopliteal artery disease
16. 13:20 - 13:25
  
  The Illumina FIH study with a next generation DES – 12-months results
17. 13:25 - 13:30
  
  Discussion and conclusion
Tuesday, January 22nd: 13:30 - 15:00, Room 1 - Main Arena 1

Symposium: Strategies and innovative solutions for success in complex peripheral arterial disease

sponsored by Medtronic

Moderator:

Dierk Scheinert

Panel:

John Laird, Theodosios Bisdas, Konstantinos Stavroulakis, Jos van den Berg
1. 13:30 - 13:38
  
  Endovascular lessons learned in the last decade: what are the remaining challenges?
2. 13:38 - 14:02
  
  Live case transmission from Leipzig
3. 14:02 - 14:10
  
  Long lesions: primary stenting or DCB first?
4. 14:10 - 14:18
  
  Calcium: The Achilles heel of endovascular? Scaffold or remove before drug delivery?
5. 14:18 - 14:42
  
  Live case transmission from New York
6. 14:42 - 14:49
  
  Dissections: prevent, minimize, or repair
7. 14:49 - 15:00
  
  Discussion and conclusion
Tuesday, January 22nd: 15:00 - 16:30, Room 1 - Main Arena 1

Symposium: Virtues of VIRTUS: Exploring implications for clinical practice

supported with an educational grant from Boston Scientific

Moderator:

Stephen Black

Panel:

Mahmood Razavi, Michael Lichtenberg, Luis Izquierdo, Lowell Kabnick
1. 15:00 - 15:05
  
  Welcome and introduction
2. 15:05 - 15:20
  
  VIRTUS: Trial design and primary endpoint results
3. 15:20 - 15:25
  
  Panel discussion and questions
4. 15:25 - 15:35
  
  Complexities of chronic venous disease
5. 15:35 - 15:45
  
  Imaging, its central role in planning and guiding intervention
6. 15:45 - 16:00
  
  VICI VENOUS STENT: Design attributes & patient outcome
7. 16:00 - 16:20
  
  Live case transmission from Galway
8. 16:20 - 16:30
  
  Panel discussion and questions
Tuesday, January 22nd: 16:30 - 18:00, Room 1 - Main Arena 1

Advanced solutions for complex femoral lesions and critical limb ischemia

Moderator:

John Laird, Marc Bosiers

Panel:

Jos van den Berg, Yann Gouëffic, Lawrence Garcia, Stefan Müller-Hülsbeck, Brian DeRubertis, Torsten Fuß
1. 16:30 - 16:36
  
  True minimally invasive access strategies for complex peripheral interventions
2. 16:36 - 17:02
  
  Live case transmission from Leipzig
3. 17:02 - 17:07
  
  First time data release: Can Legflow® improve treatment of long femoropopliteal lesions: the REFLOW outcomes
4. 17:07 - 17:12
  
  First time data release: Total IN.PACT™ 1-year results: Complex lesion outcomes from the IN.PACT study series
5. 17:12 - 17:18
  
  IN.PACT Admiral DCB: a look at long lesion outcomes across trials
6. 17:18 - 17:24
  
  From research to practice: how does atherectomy fit in my treatment algorithm
7. 17:24 - 17:50
  
  Live case transmission from New York
8. 17:50 - 17:55
  
  REALITY: Initial experience
9. 17:55 - 18:00
  
  Phoenix atherectomy: technique and real-world evidence
Wednesday, January 23rd: 8:00 - 9:30, Room 1 - Main Arena 1

Optimizing the treatment of BTK vessels in critical limb ischemia: Focus on new trials, drug-eluting technologies, and new implants

Moderator:

Dierk Scheinert, Jihad Mustapha

Panel:

Marc Bosiers, Peter Schneider, Ehrin Armstrong, Frank Vermassen, Ramon Varcoe, Francesco Liistro
1. 08:00 - 08:05
  
  Update on the BEST-trial: How will it change our practice
2. 08:05 - 08:10
  
  Endovascular treatment vs. bypass surgery in CLI patients with chronic kidney disease
3. 08:10 - 08:15
  
  First time data release: In depth look at Lutonix safety events with difficult lesion 6 month BTK IDE Update
4. 08:15 - 08:20
  
  First time data release: Interim 24 month results from the global LUTONIX® 014 DCB real world BTK registry
5. 08:20 - 08:25
  
  First time data release: Paclitaxel-coated balloon in below-the-knee lesions: 6 month results from the Ranger BTK single center study
6. 08:25 - 08:30
  
  First time data release: Initial experience with the temporary spur stent system: DEEPER trial first-in-man results
7. 08:30 - 08:35
  
  New DCB era for BTK: 6-months results from the China AcoArt II study
8. 08:35 - 08:40
  
  Drug-coated balloons in BTK: Where do we stand and what are the open questions?
9. 08:40 - 08:45
  
  Alternative methods of drug delivery in BTK vessels – Initial insights from the TANGO trial
10. 08:45 - 09:05
  
  Live case transmission from Leipzig
11. 09:05 - 09:10
  
  How to reduce dissections in BTK: Techniques & devices
12. 09:10 - 09:15
  
  Size matters: experimental study on the effect of oversizing during tibial PTA
13. 09:15 - 09:20
  
  Initial experience with a new 3F compatible microstent for BTK revascularisation
14. 09:20 - 09:25
  
  The demise of the absorb BVS. Why it failed, what we learned from the coronary experience, and is there is a future for bioresorbable scaffolds below-the-knee?
15. 09:25 - 09:30
  
  Discussion and conclusion
Wednesday, January 23rd: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: Data supported solutions for peripheral arterial disease intervention

supported with an educational grant from Boston Scientific

Moderator:

Dierk Scheinert, Yann Gouëffic

Panel:

Konstantinos Katsanos, Costantino del Giudice, Stefan Müller-Hülsbeck
1. 09:30 - 09:32
  
  Introduction and learning objectives
2. 09:32 - 09:47
  
  Benchmarking Ranger drug-coated balloon data in SFA treatment
3. 09:47 - 10:02
  
  Downstaging complexity for a DCB strategy in claudicants
4. 10:02 - 10:27
  
  Live case transmission from Leipzig
5. 10:27 - 10:42
  
  Gauging performance in below-the-knee intervention
6. 10:42 - 10:57
  
  Raising the bar with Eluvia drug-eluting stent data
7. 10:57 - 11:00
  
  Close and take aways
Wednesday, January 23rd: 11:00 - 12:30, Room 1 - Main Arena 1

Optimizing the treatment of BTK vessels in critical limb ischemia: Focus on imaging, revascularisation strategies, atherectomy, and assessment of results

Moderator:

Peter Schneider, Roberto Ferraresi

Panel:

Jim A. Reekers, Miguel Montero-Baker, George Adams, Yoshimitsu Soga, Marco Manzi
1. 11:00 - 11:05
  
  Critical limb ischemia: Have we made improvement in classifying these patients in a better way?
2. 11:05 - 11:11
  
  Tips and tricks to optimize preinterventional imaging with CO2 angiography and no-contrast MR angiography
3. 11:11 - 11:17
  
  Wound and surgery-guided revascularisation & flow-guided surgery: the multidisciplinary approach to limb salvage
4. 11:17 - 11:23
  
  When is below-the-ankle angioplasty indicated and how to introduce it into your practice?
5. 11:23 - 11:43
  
  Live case transmission from Münster
6. 11:43 - 11:48
  
  How to optimize acute success and drug effect of DCB in BTK vessels?
7. 11:48 - 11:54
  
  The role of orbital atherectomy for optimization of BTK revascularisation results
8. 11:54 - 12:00
  
  Versatility of directional atherectomy: Clinical use below-the-knee
9. 12:00 - 12:06
  
  Assessing foot perfusion after BTK revascularisation: Role of perfusion angiography and upcoming techniques
10. 12:06 - 12:11
  
  Perfusion imaging of the foot in CLI-patients: prognostic value of pharmacological interventions
11. 12:11 - 12:16
  
  Is non-functional microcirculation the same as flow-independent ischemia?
12. 12:16 - 12:30
  
  Discussion and conclusion
Wednesday, January 23rd: 12:30 - 13:30, Room 1 - Main Arena 1

Focus session: Pioneering approaches for “no-option” patients

partially supported with an educational grant from LimFlow

live from Leipzig:

Steven Kum, Andrej Schmidt

Moderator:

Jihad Mustapha, Marianne Brodmann

Panel:

Roberto Ferraresi, Peter Schneider, Ehrin Armstrong
1. Flash presentation: No option CLI – A rising epidemic and an overview of solutions
2. Flash presentation: Surgical and hybrid venous arteriolisation – How to perform it and what are the limitations
3. Flash presentation: Update on the PROMISE I early feasibility study in the US and global experience
4. Flash presentation: Rationale and design of a pivotal study for an autologous blood filter device for treatment of critical limb ischemia
Wednesday, January 23rd: 13:30 - 15:00, Room 1 - Main Arena 1

Symposium: Lutonix® DCB – The next clinically proven frontier for SFA, BTK, and AV treatment algorithms

supported with an educational grant from C. R. Bard

Moderator:

Dierk Scheinert

Panel:

Koen Deloose, Patrick Geraghty, Aloke Finn, Scott Trerotola, Yoshimitsu Soga
1. 13:30 - 13:40
  
  Global CTO analyses of all Lutonix DCB SFA combined trials
2. 13:40 - 13:50
  
  A closer look at the benefit of LTX DCB in diabetic patient in Japan
3. 13:50 - 14:00
  
  Comparison of overall LTX BTK IDE 6-month outcomes to global registry
4. 14:00 - 14:10
  
  Comparative studies of downstream events with drug coated balloon
5. 14:10 - 14:20
  
  Sub-group analysis from LTX AV randomised trial
6. 14:20 - 14:30
  
  Review and comparisons of DCB global registries
7. 14:30 - 14:55
  
  Live case transmission from Leipzig
8. 14:55 - 15:00
  
  Discussion and conclusion
Wednesday, January 23rd: 15:00 - 16:30, Room 1 - Main Arena 1

VIVA@LINC: Carotid revascularisation redux: A whole new horizon?

Moderator:

Peter Schneider, Chris Metzger

Panel:

Sean Lyden, William Gray, John Laird, Ehrin Armstrong
1. 15:00 - 15:05
  
  Announcement of the winners of the Vascular Carreer Award 2018
2. 15:05 - 15:30
  
  Live case transmission from Columbus
3. 15:30 - 15:38
  
  Transcervical carotid stenting (TCAR) is a game changer and a re-boot for CAS
4. 15:38 - 15:46
  
  Cognitive decline with untreated carotid lesions: fact or fiction?
5. 15:46 - 15:54
  
  Timing of carotid bifurcation repair after symptoms: how does it affect stroke risk?
6. 15:54 - 16:22
  
  Live case transmission from Columbus
7. 16:22 - 16:30
  
  Will mesh covered stents help reduce the risk of stroke?
Wednesday, January 23rd: 16:30 - 18:00, Room 1 - Main Arena 1

The remaining challenges: Long CTO lesions and in-stent restenosis

Moderator:

Sean Lyden, Ramon Varcoe

Panel:

James McKinsey, Michael Dake, Jorge Fernández Noya, Sabine Steiner, Dai-Do Do
1. 16:30 - 16:36
  
  First time data release: Intravascular ultrasound supported endovascular therapy in superficial femoral artery disease: 12-months results from the IVORY-study
2. 16:36 - 16:42
  
  Insights from Global Zilver PTX experience: What are the predictors for clinical failure and TLR?
3. 16:42 - 16:48
  
  CTO vs. non-CTO lesions: What are the lessons learned from the Real-PTX trial and the concept of the BEST-SFA trial?
4. 16:48 - 17:13
  
  Live case transmission from Leipzig
5. 17:13 - 17:19
  
  Complex case review: Versatility of the GORE® VIABAHN® endoprosthesis in the treatment of challenging peripheral disease
6. 17:19 - 17:25
  
  Combination therapy tackling ISR: laser + DCB 2-year results
7. 17:25 - 17:31
  
  Advancing laser therapy: different settings for different lesions
8. 17:31 - 17:56
  
  Live case transmission from Columbus
9. 17:56 - 18:00
  
  Discussion and conclusion
Thursday, January 24th: 8:00 - 9:30, Room 1 - Main Arena 1

The last frontiers: Extreme BTK interventions

Moderator:

Chris Metzger, Roberto Ferraresi

Panel:

Robert Beasley, Jihad Mustapha, Wei Guo, Francesco Liistro, Marianne Brodmann, Luis Mariano Palena
1. 08:00 - 08:21
  
  Live case transmission from Abano Terme
2. 08:21 - 08:29
  
  SAD transmission & BAD distribution: who is today a no-option CLI patient?
3. 08:29 - 08:37
  
  Peroneal access technique: How I do it and when do I consider it?
4. 08:37 - 08:45
  
  Calcified below-the-knee lesions – overview of treatment options
5. 08:45 - 09:06
  
  Live case transmission from Leipzig
6. 09:06 - 09:14
  
  An evaluation of drug eluting technologies for BTK treatment
7. 09:14 - 09:22
  
  DCB in BTK: Why and where should we use it
8. 09:22 - 09:30
  
  Prestige pilot: Phoenix atherectomy and Stellarex DCB in infrapopliteal interventions
Thursday, January 24th: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: Mechanical atherectomy and thrombectomy of arterial and venous occlusions

supported with an educational grant from Straub Medical

Moderator:

Dierk Scheinert, Romaric Loffroy

Panel:

Bruno Freitas, Christian Wissgott, Michael Lichtenberg
1. 09:30 - 09:40
  
  Atherectomy and thrombectomy of femoropopliteal occlusions with Rotarex ®S: The Leipzig experience
2. 09:40 - 10:10
  
  Live case transmission from Leipzig
3. 10:10 - 10:20
  
  Retrospective analysis of initial results of an atherothrombectomy device in patients with acute, subacute, and chronic lower limb artery occlusion
4. 10:20 - 10:50
  
  Live case transmission from Leipzig
5. 10:50 - 11:00
  
  Safety, procedural success, and outcomes of the Aspirex® S endovascular thrombectomy system in the treatment of iliofemoral deep vein thrombosis: data from the Arnsberg Aspirex registry
Thursday, January 24th: 11:00 - 12:30, Room 1 - Main Arena 1

Endo-vascular transcendence in end stage renal disease

supported with an educational grant from C. R. Bard

Moderator:

Dierk Scheinert

Panel:

Robert Jones, Bart Dolmatch, Panagiotis Kitrou, Roberto Ferraresi, Tobias Steinke, Robert Shahverdyan
1. 11:00 - 11:08
  
  Endovascular therapy first in ESRD
2. 11:08 - 11:16
  
  CLI in ERSD. Upper & lower limb ischemia
3. 11:16 - 11:24
  
  WavelinQ endo-vascular access creation
4. 11:24 - 11:32
  
  Different approaches in WavelinQ endo-vascular access
5. 11:32 - 11:42
  
  Recorded case presentation
6. 11:42 - 11:52
  
  Treating the dysfunctional AV. From algorithm to Tips & Tricks
7. 11:52 - 11:57
  
  Proof is in the evidence
8. 11:57 - 12:22
  
  Live case transmission from Münster
9. 12:22 - 12:30
  
  Discussion and conclusion
Thursday, January 24th: 12:30 - 13:30, Room 1 - Main Arena 1

Lunch
Thursday, January 24th: 13:30 - 15:00, Room 1 - Main Arena 1

The last frontiers: Endovascular therapy of the common femoral artery and the popliteal segment

Moderator:

Lawrence Garcia, Yann Gouëffic

Panel:

Sebastian Debus, Frank Criado, Erwin Blessing, Matthew Menard, Wei Liang
1. 13:30 - 13:35
  
  Long term (10 years) outcomes using VIABAHN for the treatment of PAA
2. 13:35 - 13:55
  
  Live case transmission from Leipzig
3. LINC STATUS UPDATE: MANAGEMENT OF COMMON FEMORAL DISEASE
4. 13:55 - 14:00
  
  Lesions of the CFA: Increasing evidence for endovascular rather than open repair!
5. 14:00 - 14:05
  
  I disagree: Surgical reconstruction is still the gold standard for CFA reconstruction
6. 14:05 - 14:10
  
  Panel discussion and audience vote
7. 14:10 - 14:35
  
  Live case transmission from Bad Krozingen
8. 14:35 - 14:40
  
  Intravascular Lithotripsy as a treatment option for calcified stenosis of the common femoral artery: initial experiences
9. 14:40 - 14:45
  
  Directional atherectomy and anti-restenotic therapy for CFA disease
10. 14:45 - 14:50
  
  2-year outcomes of directional atherectomy and anti-restenotic therapy in CFA disease
11. 14:50 - 14:55
  
  A valuable alternative for CFA endarterectomy? The use of the Supera vascular mimetic implant for the treatment of atherosclerotic disease in the CFA: 12-month results of the VMI-CFA study
12. 14:55 - 15:00
  
  Bifurcation stenting of the common femoral artery – long term follow up of Supera cases using the Culotte technique
Thursday, January 24th: 15:00 - 18:00, Room 1 - Main Arena 1

Disruptive treatment approaches and pioneering techniques for patients with vascular disease

partially supported with an educational grant from Bayer AG

Moderator:

William Gray, Sebastian Debus

Panel:

Rupert Bauersachs, Marianne Brodmann, George Adams, Ramon Varcoe, Ehrin Armstrong
1. FOCUS ON INNOVATIONS IN DRUG THERAPY
2. 15:00 - 15:08
  
  Understanding the latest evidence with Rivaroxaban vascular dose in PAD treatment
3. 15:08 - 15:16
  
  How can the COMPASS PAD data be applied to daily clinical practice?
4. FOCUS ON INNOVATIONS FOR VESSEL PREPARATION
5. 15:16 - 15:22
  
  What lessons have we learned from DEFINITIVE AR
6. 15:22 - 15:47
  
  Live case transmission from Münster
7. FOCUS ON INNOVATIONS IN IMPLANT TECHNOLOGY
8. 15:47 - 15:53
  
  Future of stenting in the current DCB world
9. 15:53 - 15:59
  
  Interim 2-year results from the MIMICS-2 study
10. 15:59 - 16:21
  
  Live case transmission from Leipzig
11. 16:21 - 16:43
  
  Live case transmission from Bad Krozingen
12. 16:43 - 16:49
  
  Characterizing the relationship between oxygen measured by subcutaneous micorsensors during revascularisation procedures and wound healing in CLI patients
13. 16:49 - 16:55
  
  Update on MIMICS-3D: Emerging real world registry data
14. FOCUS ON INNOVATIONS FOR COMPLEX FEMORAL LESIONS - THE PERCUTANEOUS BYPASS TECHNIQUE
15. 16:55 - 17:01
  
  Taking the scenic route: A complex case from the DETOUR II trial
16. 17:01 - 17:07
  
  First time data release: Extreme SFA lesions: DETOUR I 12-month results in lesions >30cm
17. 17:07 - 17:13
  
  Durability of the DETOUR procedure for percutaneous fem-pop bypass: 3-year follow-up from my first case
18. FOCUS ON STRATEGIES TO OPTIMIZE ASSESSMENT OF REVASCULARISATION RESULTS
19. 17:13 - 17:19
  
  Perfusion angiography: towards new standards for optimized treatment outcomes
20. 17:19 - 17:44
  
  Live case transmission from Abano Terme
21. FOCUS ON VENOUS DISEASE
22. 17:44 - 17:50
  
  Endovenous Valve Formation (EVF) – an initial report on the human clinical trial of the first non-implantable, endovenous approach to deep vein reflux
23. 17:50 - 18:00
  
  Discussion and conclusion
Friday, January 25th: 9:00 - 13:00, Room 1 - Main Arena 1

Critical issues and pioneering solutions in aortic endografting - Join us for brunch, served from 08:45am until 11:00am

Moderator:

Martin Malina

Panel:

Marc van Sambeek, Thomas Larzon, Olaf Richter, Frank Veith

live from Münster:

Martin Austermann
1. Treatment of ruptured aortic aneurysms – surgery vs. EVAR
2. Why the randomized trials comparing EVAR with open repair for ruptured AAAs are misleading and not generally applicable
3. With adjuncts (Chimney grafts and Onyx) 100% of RAAAs can be treated by EVAR with low 30-day mortality and turn down rate
4. R-EVAR is it feasible, how to deal with abdominal compartemental syndrome, pros and cons
5. Leaking huge AAA and bilateral iliac aneurysms. How vascular plugs help to save life during emergency EVAR
6. Physician modified endograft (PMEG) for EVAR
7. Urgent endovascular treatment of left uretero-iliac fistula in patient with radical cystectomy and ileal conduit urinary diversion
8. An expansion of EVAR by EVAS: a possibility in emergencies
9. Management of infected aneurysms and grafts
10. A successful treatment of an infected saccular aortic aneurysm (PAU) by Chimney- EVAS: Case report
11. Tips and tricks for obtaining supraceliac aortic control with EVAR for ruptured AAAs: it is not simple
12. Trouble shooting and bail-out in FEVAR/BEVAR
13. Nobilizing the chEVAR experience through standardization; How a standard approach improves patient outcomes
14. Emergent use of an arch branch device to treat an ascending aortic rupture with use of a branch-to-branch through-and-through wire

Room 2 - Main Arena 2

20 events

Tuesday, January 22nd: 8:00 - 9:30, Room 2 - Main Arena 2

Acute deep vein thrombosis

Moderator:

Rick de Graaf, Michael Lichtenberg

Panel:

Stephen Black, Houman Jalaie, Olivier Hartung, Tim Sebastian
1. 08:00 - 08:10
  
  Ascending femoropopliteal DVT without iliac vein involvement: any role for endovascular therapy
2. 08:10 - 08:20
  
  Ultrasound-assisted thrombolysis for acute DVT: effect of ultrasound waves and microbubbles on thrombus removal
3. 08:20 - 08:30
  
  The CAVA study, what can we expect?
4. 08:30 - 08:40
  
  Evidence for endovascular therapy of iliofemoral DVT: CAVENT, ATTRACT, CAVA, uncontrolled studies
5. 08:40 - 08:50
  
  Anticoagulation therapy following endovascular therapy of iliofemoral DVT
6. 08:50 - 09:10
  
  Live case transmission from Zurich
7. 09:10 - 09:30
  
  Live case transmission from Galway
Tuesday, January 22nd: 9:30 - 11:00, Room 2 - Main Arena 2

Aorto iliac obstructive disease: Endoluminal solutions

partially supported with an educational grant from Gore & Associates

Moderator:

Michele Antonello, Hans Krankenberg

Panel:

Koen Deloose, Patrice Mwipatayi, Gianmarco de Donato, Sean Lyden, Frank Vermassen
1. 09:30 - 09:36
  
  Complexity of iliac occlusive disease, current treatment algorithm, and treatment gaps
2. 09:36 - 09:42
  
  Crossing techniques for complex aortoiliac obstructions – Why is the bi-directional approach the best?
3. 09:42 - 09:48
  
  Self-expanding vs. balloon-expandable stents for iliac artery disease: Is either superior?
4. 09:48 - 10:15
  
  Live case transmission from Leipzig
5. 10:15 - 10:20
  
  The value of covered stents in treatment of complex TASC C and D iliac lesions: the initial experiences with the BELSTREAM study
6. 10:20 - 10:25
  
  First time data release: The BOLSTER study with the Lifestream covered stent in iliac lesions – 3-year outcomes
7. 10:25 - 10:35
  
  Case discussion: Challenging bilateral iliac case treated with VBX
8. 10:35 - 10:45
  
  Case discussion: Covered self-expandable endoprosthesis and dual component stent for iliac treatment
9. 10:45 - 10:55
  
  Case discussion: Aorto iliac case with covered balloon expandable stent
10. 10:55 - 11:00
  
  Discussion and conclusion
Tuesday, January 22nd: 11:00 - 12:30, Room 2 - Main Arena 2

Venous stent placement for post-thrombotic syndrome

Moderator:

Houman Jalaie, Stephen Black

Panel:

Robert Lookstein, Mahmood Razavi, Ramon Varcoe, Oliver Schlager
1. 11:00 - 11:10
  
  VENOVO® venous stent – 12-month update on the Vernacular trial
2. 11:10 - 11:25
  
  Live case transmission from Zurich
3. 11:25 - 11:40
  
  Live case transmission from Galway
4. 11:40 - 11:50
  
  Update on performance of venous stents for PTS patients
5. 11:50 - 12:00
  
  First time data release: VIRTUS trial: Pivotal cohort 12-month primary safety and efficacy results of the Vici venous stent system
6. 12:00 - 12:10
  
  IVUS and pressure gradients for PTS treatment: mandatory or fancy?
7. 12:10 - 12:20
  
  Live case transmission from Zurich
8. 12:20 - 12:30
  
  Live case transmission from Galway
Tuesday, January 22nd: 12:30 - 13:25, Room 2 - Main Arena 2

Lunch symposium: Treating PAD in the SFA: “Challenge the status quo” – Revealing new evidence to provide the answers

supported with an educational grant from Cook Medical

Moderator:

Michael Dake

Panel:

Marc Bosiers, Iris Baumgartner-Peuker, Robert Beasley
1. 12:30 - 12:33
  
  Introduction
2. 12:33 - 12:43
  
  Zilver PTX Global data analysis highlights DES benefits in challenging patient populations
3. 12:43 - 12:53
  
  Tried and True: Evaluating the momentary hype
4. 12:53 - 13:03
  
  Follow the data: Your 2019 treatment algorithm
5. 13:03 - 13:13
  
  Zilver PTX vs. Bypass: One year results: ZILVERPASS
6. 13:13 - 13:25
  
  Summary of symposium, discussion, and debate
Tuesday, January 22nd: 13:30 - 15:00, Room 2 - Main Arena 2

New concepts for AV-shunt revascularisation and central vein stenoses

Moderator:

Robert Lookstein, Ramon Varcoe

Panel:

Jernej Lučev, Scott Trerotola, Panagiotis Kitrou, Konstantinos Katsanos, Robert Jones
1. 13:30 - 13:36
  
  Endovascular treatment of haemodialysis arteriovenous fistula
2. 13:36 - 13:41
  
  COVERA™ – 6-month update on AVeNEW trial design for outflow stenosis in AV fistula circuits
3. 13:41 - 13:47
  
  Effectiveness of stent-grafts for the treatment of central venous disease in haemodialysis patients with functioning arteriovenous (AV) fistulas
4. 13:47 - 14:07
  
  Live case transmission from Galway
5. 14:07 - 14:12
  
  First time data release: IN.PACT AV access drug-coated balloon study: Full baseline characteristics
6. 14:12 - 14:17
  
  First time data release: 24-months results from LUTONIX AV randomized IDE trial
7. 14:17 - 14:22
  
  First time data release: Final 6-month results from the LUTONIX® Global AV registry
8. 14:22 - 14:30
  
  Presentation of recorded cases
9. 14:30 - 14:35
  
  Singapore & Taiwan experience with the Lutonix DCB in the AV registry
10. 14:35 - 14:40
  
  First time data release: 4Fr WavelinQ EndoAVF system latest 6-month clinical outcomes
11. 14:40 - 14:50
  
  Recorded case presentation
12. 14:50 - 15:00
  
  Discussion and conclusion
Tuesday, January 22nd: 15:00 - 16:30, Room 2 - Main Arena 2

Symposium: Dual layer mircromesh – taking the latest technology to the next level

supported with an educational grant from Terumo

Moderator:

Giovanni Torsello

Panel:

Stefan Müller-Hülsbeck, Piero Montorsi, Torsten Fuß
1. 15:00 - 15:10
  
  How the Roadsaver stent changed my practice in CAS
2. 15:10 - 15:20
  
  The impact of stent design and embolic protection on safety of CAS interventions
3. 15:20 - 15:45
  
  Live case transmission from Bergamo
4. 15:45 - 15:55
  
  My journey with Roadsaver through the last four years
5. 15:55 - 16:05
  
  Latest experience with dual layer stents in the lower limbs
6. 16:05 - 16:30
  
  Live case transmission from Berlin
Tuesday, January 22nd: 16:30 - 18:00, Room 2 - Main Arena 2

Scrub-in with the experts: Endovascular therapy of chronic deep vein obstructions

live from Zurich:

Nils Kucher

live from Galway:

Gerard O'Sullivan

Moderator:

Stephen Black

Panel:

Michael Dake, Mahmood Razavi, Klaus Mathias, Tim Sebastian, Houman Jalaie
1. Flash presentation: Endovascular techniques for difficult deep vein obstructions
2. Flash presentation: Endophlebectomy plus stent vs. stent reconstruction alone for PTS patients with poor inflow vessels
3. Flash presentation: Antithrombotic therapy following stent reconstruction for PTS: real word practice and the planned ARIVA trial
Wednesday, January 23rd: 8:00 - 9:15, Room 2 - Main Arena 2

Complex iliac artery aneurysms – current techniques for endovascular repair

Moderator:

Giovanni Torsello, Armando Lobato

Panel:

James McKinsey, Spiridon Botsios, Fabio Verzini, Olaf Richter
1. 08:00 - 08:06
  
  Results of the multicenter pELVIS registry for isolated common iliac aneurysms treated by the iliac branch device
2. 08:06 - 08:12
  
  Bilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry
3. 08:12 - 08:18
  
  Long-term outcomes of the COOK IBD for iliac artery aneurysms
4. 08:18 - 08:46
  
  Live case transmission from Münster
5. 08:46 - 08:52
  
  Iliac branch device GoWell: a prospective, multiple centers research results from China
6. 08:52 - 08:58
  
  Sandwich technique for treating AAAs involving the common Iliac bifurcations: Experience with 151 hypogastric revascularisations: Lessons learned
7. 08:58 - 09:04
  
  Overtaking technical and anatomical challenges of preservation in the treatment of iliac aneurysmal disease
8. 09:04 - 09:10
  
  Bilateral iliac aneurysm: what to preserve?
9. 09:10 - 09:15
  
  Discussion and conclusion
Wednesday, January 23rd: 9:15 - 11:00, Room 2 - Main Arena 2

Innovations for daily practice: Advanced settings for hybrid ORs and new technologies for “standard” infrarenal aortic aneurysm repair

Moderator:

Frans Moll, Marc van Sambeek

Panel:

Jörg Teßarek, Joost A. van Herwaarden, Frank Veith, Chang Shu, Mauro Gargiulo
1. FOCUS ON CONSIDERATIONS AND INNOVATIVE SOLUTIONS FOR HYBRID ORS
2. 09:15 - 09:21
  
  Workflow innovation in the hybrid OR space
3. 09:21 - 09:27
  
  Sterility in the hybrid OR – A crucial hygiene factor
4. 09:27 - 09:33
  
  Rationale for IVUS guided endovascular aortic repair
5. 09:33 - 09:39
  
  First time data release: Innovation in 3D navigation: results from the FORS – Fibre Optic RealShape first in-human study
6. 09:39 - 09:45
  
  Occupational radiation hazards during EVAR
7. FOCUS ON CURRENT DATA AND NEW TECHNOLOGIES FOR "STANDARD EVAR"
8. 09:45 - 09:50
  
  Women experience clinically comparable long-term outcomes to men when treated with the Endurant endograft: a 5-year evaluation of 133 female patients from the ENGAGE registry
9. 09:50 - 10:10
  
  Live case transmission from Leipzig
10. 10:10 - 10:15
  
  Does ovation offer a long-term durable solution for female AAA patients? Results from ENCORE gender sub-analysis
11. 10:15 - 10:20
  
  Results in EVAR, FEVAR, and BEVAR: are differences between men and women still present?
12. 10:20 - 10:28
  
  Recorded case presentation: Abdominal aortic aneurysm repair with Lifetech Ankura AAA stent graft sytem
13. 10:28 - 10:33
  
  Early experience with Ankura AAA stent graft system
14. 10:33 - 10:38
  
  Single-centre experience with the Gore C3 Excluder stent-graft in 300 consecutive patients
15. 10:38 - 10:43
  
  Might EVAS be associated with a difference in mortality compared to EVAR?
16. 10:43 - 10:48
  
  Contemporary EVAR evidence demonstrated clear improvement in long-term outcomes compared to EVAR-1: Insights from the ENGAGE global registry
17. 10:48 - 10:53
  
  Final results of the RATIONALE registry with the Treovance stent-graft
18. 10:53 - 11:00
  
  Discussion and conclusion
Wednesday, January 23rd: 11:00 - 12:30, Room 2 - Main Arena 2

Challenges in the treatment of infrarenal aneurysms – considerations for a durable repair

supported with an educational grant from Cook Medical

Moderator:

Eric Verhoeven

Panel:

Nilo Mosquera, Fabio Verzini
1. 11:00 - 11:05
  
  Introduction
2. 11:05 - 11:13
  
  Challenges in the treatment of infrarenal aneurysm – considerations for a durable repair
3. 11:13 - 11:38
  
  Live case transmission from Leipzig
4. 11:38 - 11:46
  
  Keypoints when treating short necks
5. 11:46 - 12:30
  
  Discussion and conclusion
Wednesday, January 23rd: 13:30 - 15:00, Room 2 - Main Arena 2

Symposium: GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis: bridge the gaps for aortic complex disease

supported with an educational grant from Gore & Associates

Moderator:

Dittmar Böckler

Panel:

Giovanni Torsello, Jorge Fernández Noya, Mauro Gargiulo
1. 13:30 - 13:35
  
  Introduction by the moderator
2. 13:35 - 13:50
  
  Advantages of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis: technical and clinical value in treating aortic disease
3. 13:50 - 14:05
  
  Performance of bridging stents for fenestrated endovascular repair
4. 14:05 - 14:20
  
  Recorded case presentation
5. 14:20 - 14:35
  
  1-year data
6. 14:35 - 14:50
  
  Live case transmission from Münster
7. 14:50 - 15:00
  
  Discussion and conclusion by the moderator
Wednesday, January 23rd: 15:00 - 16:30, Room 2 - Main Arena 2

CX@LINC: Endovascular aortic controversies

Moderator:

Roger Greenhalgh

Panel:

Dittmar Böckler, Tilo Kölbel
1. IMPROVING EVAR RESULTS
2. 15:00 - 15:10
  
  Reduced radiation and choice of imaging modality for endoleak detection and correction
3. 15:10 - 15:20
  
  New analyses for NICE aortic guidelines
4. 15:20 - 15:30
  
  Most EVAR procedures should be done under local anaesthetic
5. 15:30 - 15:45
  
  Audience participation and discussion
6. AVOIDING STROKE FROM THORACIC ENDOVASCULAR PROCEDURES (STEP)
7. 15:45 - 15:55
  
  Stroke from Thoracic Endovascular Procedures (STEP study) findings
8. 15:55 - 16:00
  
  Audience participation and discussion
9. 16:00 - 16:10
  
  Pre-procedure screening to minimise stroke from endovascular arch repair
10. 16:10 - 16:15
  
  Audience participation and discussion
11. 16:15 - 16:25
  
  Edited live: Ascending and arch of aorta techniques to reduce stroke risk
12. 16:25 - 16:30
  
  Audience participation and discussion
Wednesday, January 23rd: 16:30 - 18:00, Room 2 - Main Arena 2

Advanced solutions for juxtarenal aneurysms and challenging neck anatomy

Moderator:

Marc van Sambeek, Giovanni Torsello

Panel:

Thomas Larzon, Giovanni Pratesi, Daniela Branzan, Jan Brunkwall
1. 16:30 - 16:36
  
  The use of EVAR to treat extreme hostile anatomies; Insights from the EAGLE registry
2. 16:36 - 16:42
  
  Experience with Treovance in highly angulated necks
3. 16:42 - 16:48
  
  EVAR in severely angulated neck: an option with good longterm outcome
4. 16:48 - 16:54
  
  Aortic challenges, quantitative analysis in fenestrated procedures
5. 16:54 - 17:19
  
  Live case transmission from Münster
6. 17:19 - 17:25
  
  Early experience from the ENCHANT post-market registry on chEVAR with Endurant
7. 17:25 - 17:31
  
  Pararenal AAA: Why FEVAR must be better than CHEVAR in most cases
8. 17:31 - 17:37
  
  Update on the fenestrated Anaconda endograft for F/EVAR: worldwide experience from the global FACT registry
9. 17:37 - 17:43
  
  Early experience with Excluder conformable in a broad range of anatomies
10. 17:43 - 17:49
  
  Mid-term results from ANCHOR: How does this data influence the treatment algorightm for hostile EVAR anatomies
11. 17:49 - 17:55
  
  Complementary therapy for juxtarenal AAAs (<10 mm to 4 mm neck length): clinical results and technical insights using the Endurant + Heli-FX short neck indication
12. 17:55 - 18:00
  
  Discussion and conclusion
Thursday, January 24th: 8:00 - 9:30, Room 2 - Main Arena 2

New insights and current techniques for thoracic endovascular aortic repair (TEVAR)

Moderator:

Vicente Riambau, Giovanni Torsello

Panel:

Jan Blankensteijn, Frank Criado, Martin Malina, Dittmar Böckler
1. 08:00 - 08:06
  
  Beyond morphology: Bovine arch anatomy, classification, and implications
2. 08:06 - 08:12
  
  Extensibility and distensibility of the thoracic aorta in patients with aneurysms
3. 08:12 - 08:42
  
  Live case transmission from Münster
4. FOCUS ON NEW DEVICES FOR TEVAR
5. 08:42 - 08:48
  
  Treating challenging aortic anatomies. Are new devices the answers to overcoming current limitations?
6. 08:48 - 08:54
  
  Early insights from the clinical trial for Valiant Navion™: how Medtronic’s new low-profile TEVAR device expands therapeutic options
7. 08:54 - 09:00
  
  RelayPro regeneration trial: Update and launch
8. 09:00 - 09:06
  
  The value of conformability and control: 18 months of clinical experience in all thoracic etiologies
9. 09:06 - 09:12
  
  More than 50 cases with CTAG with active control: What did we learn?
10. 09:12 - 09:18
  
  Open conversion after failed TEVAR
11. 09:18 - 09:30
  
  Discussion and conclusion
Thursday, January 24th: 9:30 - 11:00, Room 2 - Main Arena 2

Management of aortic dissections and pioneering techniques for pathologies of the ascending aorta and the aortic arch

Moderator:

Tilo Kölbel, Frank Veith

Panel:

Wei Guo, Ralf Kolvenbach, Mario Lachat, Roberto Chiesa
1. FOCUS ON ACUTE AORTIC SYNDROMES AND AORTIC DISSECTIONS
2. 09:30 - 09:36
  
  Update on management of PAU and IMH: Lingering doubt and controversies
3. 09:36 - 09:42
  
  Recent evidence surrounding the treatment of patients with Type B dissections
4. 09:42 - 09:48
  
  Decision process and influencing factors for the treatment of uncomplicated Type B aortic dissection
5. 09:48 - 09:54
  
  Chronic aortic dissection: When to use FEVAR and when false lumen occlusion techniques
6. 09:54 - 10:18
  
  Live case transmission from Paris
7. FOCUS ON NEW APPROACHES FOR THE ASCENDING AORTA AND THE ARCH
8. 10:18 - 10:24
  
  How to manage aortic arch pathology: open, hybrid, chimney or fenestration
9. 10:24 - 10:30
  
  The current status of endovascular repair of ascending aorta and aortic arch
10. 10:30 - 10:36
  
  Ascending aortic remodelling permits TEVAR in most ascending aneurysms
11. 10:36 - 10:42
  
  Comparison of two different techniques of isolated left subclavian artery revascularisation during “Zone 2” thoracic endovascular aortic repair
12. 10:42 - 10:48
  
  RelayBranch: Expanding TEVAR to a new class of patients
13. 10:48 - 10:54
  
  Register study for Zone 0 aortic arch aneurysm with Chimney/Sandwich technique: 8-year follow-up
14. 10:54 - 11:00
  
  Updated results of the Nexus aortic stentgraft system
Thursday, January 24th: 11:00 - 12:30, Room 2 - Main Arena 2

Symposium: Active control and conformability: a new portfolio paradigm to advance care

supported with an educational grant from Gore & Associates

Moderator:

Giovanni Torsello

Panel:

Dittmar Böckler, Marc van Sambeek, Nilo Mosquera
1. 11:00 - 11:05
  
  Introduction
2. 11:05 - 11:15
  
  Benefit of the GORE® ACTIVE CONTROL System for achieving optimal outcomes in complex TEVAR procedures
3. 11:15 - 11:25
  
  Controlled conformability to make it possible: European clinical experience with the GORE® EXCLUDER® Conformable AAA Endoprosthesis
4. 11:25 - 11:50
  
  Recorded case presentation from Eindhoven
5. 11:50 - 12:00
  
  Expand the indication for iliac branching: key clinical and technical learning in the bilateral treatment
6. 12:00 - 12:25
  
  Live case transmission from Münster
7. 12:25 - 12:30
  
  Discussion and conclusion
Thursday, January 24th: 12:30 - 13:30, Room 2 - Main Arena 2

Focus session: Pioneering techniques and new concepts for prevention of stroke and paraplegia during EVAR in the thoracic and thoracoabdominal aorta

live from Leipzig:

Andrej Schmidt

Moderator:

Vicente Riambau

Panel:

Christian Etz, Daniela Branzan, Michael Jacobs, Eric Verhoeven, Michael Borger
1. Staged repair and neuromonitoring during thoracoabdominal aortic repair – is it helpful?
2. Principle of spinal cord protection in open and endovascular TAA/A repair: from bench to bedsite
3. Technical aspects and first clinical results of MISACE
4. Stroke in TEVAR: cerebral protection techniques. When and how
Thursday, January 24th: 13:30 - 15:00, Room 2 - Main Arena 2

Re-do procedures after EVAR and management of endoleaks

Moderator:

Giovanni Torsello, Marc van Sambeek

Panel:

Thomas Larzon, Michel Reijnen, James McKinsey, Reza Ghotbi, Sven Seifert
1. 13:30 - 13:36
  
  Mechanical characterisation of abdominal aortic aneurysm, using 4D ultrasound
2. 13:36 - 13:42
  
  Evolution of the peri-renal aortic neck segment after endovascular aneurysm repair with the Anaconda stent-graft
3. 13:42 - 13:48
  
  Proximal extension of disease after FEVAR: frequency and treatment options
4. 13:48 - 13:54
  
  Nellix-in-Nellix proximal extensions for late failures
5. 13:54 - 14:00
  
  Technical considerations to optimize clinical success with EndoAnchor implants
6. 14:00 - 14:25
  
  Live case transmission from Münster
7. 14:25 - 14:31
  
  Debunking the publication “predictors of abdominal aortic aneurysm sac enlargment after EVAR”; long-term results from the ENGAGE registry
8. 14:31 - 14:37
  
  Flow-dynamic study for late Type I B endoleaks in thoracic stent-grafts
9. 14:37 - 14:43
  
  What is the clinical significance of Type II endoleaks? 5-year analysis from the ENGAGE registry
10. 14:43 - 14:49
  
  Alternative approach to Type II endoleaks: Transfemoral, para-graft approach
11. 14:49 - 14:55
  
  First clinical results of aneurysm sac filling with polymers
12. 14:55 - 15:00
  
  Trouble shooting in iliac side branch failure treatment
Thursday, January 24th: 15:00 - 16:00, Room 2 - Main Arena 2

Symposium: The freedom to do more in TEVAR: New evidence and solutions to improve patient outcomes

sponsored by Medtronic

Moderator:

Dittmar Böckler

Panel:

Santi Trimarchi, Paul Hayes, Fabio Verzini, Luigi Lovato
1. 15:00 - 15:08
  
  When and how to perform TEVAR: evidence based insights
2. 15:08 - 15:16
  
  Addressing unmet clinical needs with the new generation Valiant Navion™ device
3. 15:16 - 15:24
  
  30-day results on the Valiant Navion™ device
4. 15:24 - 15:49
  
  Recorded case presentation: Valiant Navion™ device enhancements: A case-based approach to Navion's clinical value
5. 15:49 - 16:00
  
  Discussion and conclusion
Thursday, January 24th: 16:00 - 18:00, Room 2 - Main Arena 2

Latest techniques for endovascular repair of thoracoabdominal aneurysms and consideration for prevention of complications

Moderator:

Michael Jacobs, Michael Borger

Panel:

Armando Lobato, Eric Verhoeven
1. 16:00 - 16:06
  
  State of the art of thoracoabdominal aortic aneurysm open repair
2. 16:06 - 16:12
  
  Reduced morbidity and mortality after staged open repair for thoraco-abdominal aneurysms
3. 16:12 - 16:18
  
  Centralization vs. proctoring: Results in about 1.000 fenestrated and branched cases
4. 16:18 - 16:50
  
  Live case transmission from Paris
5. FOCUS ON SIDE BRANCH TECHNOLOGY
6. 16:50 - 16:55
  
  Performance of different bridging stentgrafts in a fenestrated model after flairing. An in vitro study
7. 16:55 - 17:00
  
  Failure modes of visceral branches in EVAR: Implications for branch design
8. 17:00 - 17:05
  
  Why is it so important to use the right stent in FEVAR?
9. 17:05 - 17:10
  
  18 months of follow-up on the BeGraft PLUS in BEVAR cases
10. 17:10 - 17:15
  
  Early experience of VBX in branched procedures
11. 17:15 - 17:23
  
  Recorded case presentation: Complex FEVAR using Fenestrated Anaconda and RelayPlus
12. 17:23 - 17:29
  
  Update on the sandwich technique for treating complex TAAAs: Technical tips, precautions, and results
13. 17:29 - 17:35
  
  Tips and tricks for the percutaneous axillary artery access during complex endovascular aortic procedures
14. 17:35 - 17:41
  
  Early PS-IDE experience with the off-the-shelf Valiant™ thoracoabdominal device
15. 17:41 - 17:47
  
  Inner branches: a third option to address “non-suitable” visceral target vessels in FEVAR/BEVAR. Indication, technique, and limitations
16. 17:47 - 17:52
  
  Should upper extremity access be avoided in BEVAR: when to use deflectable sheaths
17. 17:52 - 17:57
  
  Post-implantation inflammatory response after EVAR
18. 17:57 - 18:00
  
  Discussion and conclusion

Room 3 - Technical Forum

18 events

Tuesday, January 22nd: 9:00 - 11:30, Room 3 - Technical Forum

Management of carotid artery disease: Remaining controversies, latest technologies, and challenges ahead

Moderator:

Horst Sievert, Alison Halliday

Panel:

Martin Storck, Giancarlo Biamino, Frank Veith
1. 09:00 - 09:06
  
  Assessment of carotid plaque morphology using photoacoustic imaging
2. 09:06 - 09:12
  
  LINC status update: Management of asymptomatic stenose: Medical therapy is usually sufficient for asymptomatic carotid stenosis. What are the exceptions?
3. 09:12 - 09:18
  
  LINC status update: Management of asymptomatic stenose: Carotid repair is best for asymptomatic carotid stenosis because medical management alone does not work
4. 09:18 - 09:23
  
  Status update on the ongoing trials looking at asymptomatic carotid stenoses
5. 09:23 - 09:26
  
  Audience vote
6. 09:26 - 09:51
  
  Live case transmission from Berlin
7. 09:51 - 09:57
  
  Carotid interventions – is there a gender difference in outcome?
8. 09:57 - 10:03
  
  40 years of carotid angioplasty – A glance back
9. 10:03 - 10:15
  
  LINC status update: Is carotid stenting largely equivalent to carotid endartherectomy for the majority of patients with significant carotid disease and indication for revascularisation? What are the open questions?
10. 10:15 - 10:21
  
  1-year results of the SCAFFOLD study: GORE PTFE mesh-covered carotid stent
11. 10:21 - 10:27
  
  Parameters affecting the risk of embolization during carotid stenting
12. 10:27 - 10:33
  
  Initial clinical study of the new CGuard™ MicroNet®covered carotid-stent: One size fits all – experimental data and clinical results
13. 10:33 - 10:39
  
  Dual layer stents for CAS: all you need to know to avoid acute re-occlusion
14. 10:39 - 10:45
  
  Proximal protection during CAS: Why is it the superior concept?
15. 10:45 - 10:51
  
  TECAR with proximal flow reversal in symptomatic patients is superior to carotid endarterectomy no matter what kind of stent is used – results of a prospective study which includes DWMRI analysis
16. 10:51 - 10:57
  
  Avoiding and managing complications during CAS – lessons learned
17. 10:57 - 11:22
  
  Live case transmission from Bergamo
18. 11:22 - 11:30
  
  Audience vote
Tuesday, January 22nd: 11:30 - 12:30, Room 3 - Technical Forum

Focus session: Advances in stroke management

Moderator:

Franziska Dorn, Hans Henkes

Panel:

Stephan Duda, Marios Nikos Psychogios
1. 11:30 - 11:40
  
  The art of thrombectomy
2. 11:40 - 11:50
  
  Stroke treatment: New data
3. 11:50 - 12:00
  
  Time management in endovascular stroke treatment
4. 12:00 - 12:10
  
  Credentialing approaches for interventional stroke management
5. 12:10 - 12:30
  
  Discussion and conclusion
Tuesday, January 22nd: 12:35 - 13:20, Room 3 - Technical Forum

Lunch symposium: Why do we need proven balloon expandable covered stents for long term performance?

supported with an educational grant from Getinge

Moderator:

Eric Ducasse

Panel:

Eric Verhoeven, Giovanni Torsello
1. 12:35 - 12:45
  
  The 15-year evolution of covered stent: Choosing the best stent for iliac artery disease. Is COBEST a strong evidence for V12 as choice of covered stent?
2. 12:45 - 12:55
  
  Reliable performance of Advanta V12 in complex aortic cases as a renal stent
3. 12:55 - 13:05
  
  Long-term Münster experience with Advanta V12 and latest in-vitro evidence
4. 13:05 - 13:20
  
  Discussion and conclusion
Tuesday, January 22nd: 13:30 - 15:00, Room 3 - Technical Forum

Scrub-in with the experts: Innovative approaches for complex femoropopliteal lesions

partially supported with an educational grant from B. Braun Melsungen

live from Berlin:

Ralf Langhoff

live from Leipzig:

Sven Bräunlich

Moderator:

Luis Mariano Palena, Brian DeRubertis

Panel:

Klaus Amendt, Michael Lichtenberg, Chris Metzger
1. Flash presentation: Treatment algorithm for a “leaving as little as possible behind” strategy in femoro-popliteal lesions
2. Dissecting the TOBA Data: What does it mean in practice
3. INDICATIONS FOR SPOT STENTING – WHERE TO PLACE SPOT STENTS?
4. Case discussion: Major dissection treated with DCB and spot stents
5. Case discussion: Calcified long femoro-popliteal lesions treated with DCB and spot stents
6. Long-segment stenting with woven nitinol stents: the new endoluminal bypass managing
Tuesday, January 22nd: 15:00 - 16:30, Room 3 - Technical Forum

Scrub in with the experts: Challenging aortoiliac interventions

live from Leipzig:

Andrej Schmidt

live from New York:

Prakash Krishnan

Moderator:

Lawrence Garcia, Michel Reijnen

Panel:

Patrice Mwipatayi, Sigrid Nikol, Hans Krankenberg
1. Flash presentation: A series of BeGraft implantations in isolated aortic stenoses: a women’s issue?
2. Flash presentation: Acute and follow-up results of complete aortoiliac obstruction (Leriche syndrome) – The Leipzig experience
3. Flash presentation: Global CERAB study: where are we standing?
4. Flash presentation: Covered stents as a lifesaver for the patient and me in my most bizzare cases
Tuesday, January 22nd: 16:30 - 18:00, Room 3 - Technical Forum

Scrub-in with the experts: Supraaortic and brachial interventions

live from Bergamo:

Fausto Castriota, Antonio Micari

live from Leipzig:

Andrej Schmidt

Moderator:

William Gray, Horst Sievert

Panel:

Zoran Milosevic, Sean Lyden, Bernhard Reimers, Stanislaw Bartus
1. Flash presentation: Use of OCT and IVUS during CAS
2. Flash presentation: Comparison of Intravascular Ultrasound (IVUS) virtual histology during carotid artery stenting and lack of correlation with plaque embolization as measured by either clinical findings or the captured plaque observed on direct or flow-reversal filter
3. Flash presentation: Covered stents in the management of carotid artery erosion from head and neck cancers
4. Flash presentation: PTA of aortic arch vessel in patients with Takayasus disease
Wednesday, January 23rd: 8:00 - 9:30, Room 3 - Technical Forum

Focus session: Interventional oncology and embolisation therapies – Liver (part I)

Moderator:

Ulf Teichgräber, Michael Moche

Panel:

Thomas J. Vogl, Maciej Pech, Walter Wohlgemuth
1. 08:00 - 08:08
  
  Irreversible electroporation – current role in percutaneous tumor ablation
2. 08:08 - 08:33
  
  Live case transmission from Frankfurt
3. 08:33 - 08:41
  
  Clinical evidence of radioembolisation in HCC
4. 08:41 - 08:49
  
  Transarterial chemoembolisation: C-TACE vs. DEB TACE vs. DSM TACE
5. 08:49 - 09:14
  
  Live case transmission from Jena
6. 09:14 - 09:22
  
  SIRCCA trial: Radioembolisation as first line therapy in patients with inoperable intrahepatic cholangiocarcinoma
7. 09:22 - 09:30
  
  Holmium-166 radioembolisation: do we really need that?
Wednesday, January 23rd: 9:30 - 10:15, Room 3 - Technical Forum

Stop bleeding! Tips and tricks for interventional management of bleeding complications

Moderator:

Jörn Balzer, Robert Lookstein

Panel:

Boris Radeleff, Bernhard Reimers
1. 09:30 - 09:38
  
  Interventional therapies in patients under anticoagulation – risk-related management
2. 09:38 - 09:46
  
  Emergency coiling procedures for acute bleeding – tips and tricks
3. 09:46 - 09:54
  
  Interventional treatment options for bleeding of oesophageal varices
4. 09:54 - 10:02
  
  Access complications during TAVI – How to treat and how to prevent
5. 10:02 - 10:15
  
  Discussion and conclusion
Wednesday, January 23rd: 10:15 - 11:00, Room 3 - Technical Forum

Symposium: Pelvic vein disorders: Clinical presentations, differential diagnosis, and treatment options

sponsored by Medtronic

Moderator:

Stephen Black

Panel:

Vincent Vidal
1. 10:15 - 10:30
  
  Pelvic venous obstruction: Case study with Abre™
2. 10:30 - 10:40
  
  Pelvic venous obstruction: Case study with Abre™ venous stent
3. 10:40 - 10:50
  
  Pelvic venous reflux: Embolisation with the Onyx® Liquid Embolic system
4. 10:50 - 11:00
  
  Questions and answers
Wednesday, January 23rd: 11:00 - 12:30, Room 3 - Technical Forum

Focus session: Interventional oncology and embolisation therapies – Liver (part II)

Moderator:

Thomas J. Vogl, Bernhard Gebauer

Panel:

Ralf-Thorsten Hoffmann, Ulf Teichgräber, Michael Moche
1. 11:00 - 11:08
  
  Double embolisation for rapid liver hypertrophy: The endovascular ALPPS
2. 11:08 - 11:33
  
  Live case transmission from Jena
3. 11:33 - 11:41
  
  Portal vein aborisation after TIPPS implantation
4. 11:41 - 11:49
  
  Thermoablation – where do we stand?
5. 11:49 - 12:14
  
  Live case transmission from Frankfurt
6. 12:14 - 12:22
  
  Recorded case presentation: Technical aspects of portal venous embolisation
7. 12:22 - 12:30
  
  OPTIMIS: a global observational study to assess the use of Sorafenib after TACE in patients with hepatocellular carcinoma (HCC)
Wednesday, January 23rd: 13:30 - 15:00, Room 3 - Technical Forum

VIVA@LINC: Deep dive into acute lower extremity ischemia: are we making progress?

live from Columbus:

Gary Ansel

Moderator:

Sean Lyden, Peter Schneider

Panel:

Osamu Iida, Sabine Steiner, John Laird, Ehrin Armstrong
1. Flash presentation: My algorithm for managing acute lower extremity ischemia
2. Flash presentation: Insights into the pathophysiology of thrombus: Why is clot removal so difficult?
3. Flash presentation: When is open surgery or a hybrid approach indicated for acute limb ischemia and when to do fasciotomy?
4. Flash presentation: The impact of new devices and strategies on how we perform arterial thrombectomy
Wednesday, January 23rd: 15:00 - 16:30, Room 3 - Technical Forum

Focus session: Interventional radiology – embolisation therapy

Moderator:

Ulf Teichgräber, Thomas J. Vogl

Panel:

Walter Wohlgemuth, Antonio Gaetano Rampoldi, Vincent Vidal
1. 15:00 - 15:08
  
  Medium and longterm outcome of prostate artery embolisation for patients with benign prostatic hyperplasia
2. 15:08 - 15:29
  
  Live case transmission from Jena
3. 15:29 - 15:37
  
  Uterine artery embolisation (UAE) vs. laparoscopy vs. HIFU
4. 15:37 - 15:45
  
  5-year results of prostate artery embolisation from Jena University Hospital
5. 15:45 - 15:53
  
  Endovascular therapy of arterio-venous malformations: how to treat lesions with different angioanatomy
6. 15:53 - 16:14
  
  Live case transmission from Frankfurt
7. 16:14 - 16:22
  
  Interventional treatment of visceral artery and pseudoaneurysm
8. 16:22 - 16:30
  
  Emborrhoid: A new concept for the treatment of hemorrhoids with arterial embolization
Wednesday, January 23rd: 16:30 - 18:00, Room 3 - Technical Forum

Miscellaneous topics: Renal, visceral interventions, and beyond

Moderator:

William Gray, Thomas J. Vogl

Panel:

Robert Lookstein, Marcus Thieme, Philipp Lurz
1. 16:30 - 16:37
  
  Renal denervation: Is the concept still alive?
2. 16:37 - 16:44
  
  Fibromuscular dysplasia in renal arteries
3. 16:44 - 16:51
  
  Acute and chronic mesenteric ischaemia – Incidence, clinical presentation, and treatment options
4. 16:51 - 17:15
  
  Live case transmission from Jena
5. 17:15 - 17:22
  
  TIPPS – current and future applications
6. 17:22 - 17:29
  
  Endovascular techniques for visceral artery aneurysm treatment
7. 17:29 - 17:53
  
  Live case transmission from Frankfurt
8. 17:53 - 18:00
  
  Left gastric artery embolization for obesity management – Current experiences and techniques
Thursday, January 24th: 8:00 - 9:30, Room 3 - Technical Forum

CLI and CTO summit – complex aortoiliac and femoral interventions

live from Leipzig:

Sven Bräunlich

live from Bad Krozingen:

Thomas Zeller

Moderator:

John Laird, Dai-Do Do

Panel:

Sebastian Sixt, Ralf Langhoff, Brian DeRubertis
1. SELECTED ABSTRACTS - CHALLENGING CASES
2. Covered Endovascular Reconstruction of Aortic Bifurcation (CERAB-technique) in a case of common iliac artery rupture
3. Hybrid surgical treatment of bilateral aorto-femoral occlusion
4. The Chimney-CERAB for treatment of acute aortic thrombosis
5. Ultrasound-guided direct needle engagement for flush-occluded superficial femoral artery
6. Long-term follow-up after retrograde recanalisation of superficial femoral artery chronic total occlusion
Thursday, January 24th: 9:30 - 10:30, Room 3 - Technical Forum

Step by step on SFA/pop and other Supera usage technical and practical aspects

supported with an educational grant from Abbott Vascular

Moderator:

Jos van den Berg

Panel:

Jörg Teßarek, Shannon Thomas, Koen Deloose
1. 09:30 - 09:40
  
  How to perform CFA Supera deployment
2. 09:40 - 09:50
  
  How to perform AVF Supera deployment
3. 09:50 - 10:00
  
  How to perform subintimal Supera deployment with Presto technique
4. 10:00 - 10:10
  
  How to perform Supera popliteal aneurysm deployment
5. 10:10 - 10:30
  
  Discussion and conclusion
Thursday, January 24th: 10:30 - 12:00, Room 3 - Technical Forum

CLI and CTO summit – complex femoral and BTK interventions

live from Abano Terme:

Marco Manzi

live from Leipzig:

Andrej Schmidt

Moderator:

Antonio Micari, Jihad Mustapha

Panel:

Chris Metzger, Kazushi Urasawa
1. Over 1200 patients treated with pedal access from primary CTO + CLI in an outpatient setting
2. Usefulness of ankle block in case of distal puncture for below-the-knee angioplasty
3. SELECTED ABSTRACTS - CHALLENGING CASES
4. Retrograde transcollateral revascularisation of totally occluded superficial femoral artery
5. Modified snare-piercing technique for severe calcified superficial femoral artery lesion
6. Popliteal artery bifurcation reconstruction by double retrograde access of tibial arteries with kissing balloon technique
Thursday, January 24th: 13:30 - 17:00, Room 3 - Technical Forum

Pioneering techniques for critical limb ischemia and “no-option” patients

live with:

Andrej Schmidt, Marco Manzi, Thomas Zeller

Moderator:

Giancarlo Biamino

Panel:

Antonio Micari, Francesco Liistro, Konstantinos Katsanos
1. Angiosomal-guided revascularisation in critical limb ischemia
2. Direct revascularisation (DR) to improve wound healing and prevent major amputations in CLI patients with below-the-knee PAD. Case presentations and literature review
3. Percutaneous needle disruption of heavily calcified tibial artery during infrapopliteal angioplasty; personal experience with the PIERCE technique previously described by Sato et al.
4. Central wiring technique is useful for SFA occluded lesions with self ultrasonography guided method
5. Assisted tibial artery re-entry during SAFARI revascularisation
6. An endovascular treatment option for end stage desert foot in the setting of rapidly progressing critical limb ischemia by way of deep venous arterialization
Friday, January 25th: 9:00 - 13:00, Room 3 - Technical Forum

“Great saves and big disasters” – Review of challenging cases and complications – Join us for brunch, served from 08:45am until 11:00am

Moderator:

Giancarlo Biamino

Panel:

Klaus Amendt, Hans Krankenberg, Dai-Do Do

live from Leipzig:

Andrej Schmidt
1. Announcement of the winners of the LINC 2019 poster award
2. Endovascular treatment of a tracheo-carotid artery fistula (TCAF) through a covered stent placement in the common carotid artery (CCA)
3. Massive bleeding through tracheostomy site controlled by double and parallel covered stent insertion
4. The most severe distal emboli of endovascular treatment for iliac and superficial femoral artery we experienced

Room 4 - Discussion Forum

10 events

Tuesday, January 22nd: 12:30 - 13:25, Room 4 - Discussion Forum

How guidewire technology can influence procedural outcome in different approaches

supported with an educational grant from Asahi Intecc

Moderator:

Jos van den Berg
1. Different guidewire construction
2. SFA lesions guidewire selection
3. POP-BTK lesions guidewire selection
4. POP-BTK lesions guidewire selection
5. Table discussion & closing remarks from moderator
Tuesday, January 22nd: 14:00 - 15:00, Room 4 - Discussion Forum

Symposium: Are DCBs an effective treatment for SFA and BTK lesions?

supported with an educational grant from iVascular

Moderator:

Koen Deloose
1. Best DCB outcomes in SFA TASC A&B lesions – EFFPAC-RCT 12-months follow-up
2. DCB in SFA complex lesions. 1+1=3 – TINTIN trial first outcomes
3. State of the art of BTK vessel treatment
4. DCB is also a real option for BTK arteries – BIBLIOS presentation
Wednesday, January 23rd: 9:30 - 10:30, Room 4 - Discussion Forum

SITE@LINC: Aortic disaster cases: what can we learn from the expert’s nightmares?

Moderator:

Vicente Riambau, Dittmar Böckler

Discussant:

Jan Brunkwall, Jean-Paul de Vries, Eric Ducasse, Tilo Kölbel
1. Objective: To share bad and unexpected experiences and how to deal with them. Big names can also be in trouble. Case presentations and interactive discussion
Wednesday, January 23rd: 11:00 - 12:00, Room 4 - Discussion Forum

VIVA@LINC: Strategies on the frontline. The year in review: Triumph or tragedy – my most surprising case of the past year and how it changed my approach

Moderator:

Sean Lyden

Discussant:

Chris Metzger, John Laird, Osamu Iida
1. Aortic
2. Carotid
3. Femoral-popliteal
4. Tibial-pedal
5. This is a case-based session focusing on what we like best ... real cases with challenges that make the experts sweat. This may result in a great save or a terrible complication but these are often the cases from which we learn the most. In this amphitheater setting, audience participation is encouraged and step-by-step case management is featured and discussed.
Wednesday, January 23rd: 12:35 - 13:20, Room 4 - Discussion Forum

Lunch symposium: Lowest wash-off and crystal clear coating: advanced strategies for DCB safety

supported with an educational grant from Cardionovum

Moderator:

Michael Lichtenberg, Carlos Vaquero-Puerta

Discussant:

Koen Deloose, Eugenio Stabile, Christopher Hammond
1. 12:35 - 12:42
  
  SAFE PAX: The patient safety PTX coating technology
2. 12:42 - 12:52
  
  Long-term effect of the Paclitaxel releasing peripheral balloon dilatation catheter (APERTO OTW®) for arteriovenous fistulae stenosis: the evidence to date
3. 12:52 - 13:02
  
  Modern revascularisation strategy for long SFA lesions: The REFLOW outcomes
4. 13:02 - 13:12
  
  Learning from the producers: The LEGDEB experiences and 2-year outcomes
5. 13:12 - 13:20
  
  Conclusions and take home message
Wednesday, January 23rd: 14:00 - 15:00, Room 4 - Discussion Forum

Discussion forum on diabetic foot clinic and the multidisciplinary approach

supported with an educational grant from Abbott Vascular

Moderator:

Brian DeRubertis

Discussant:

Roberto Ferraresi, Thomas Zeller, Giacomo Clerici
1. Case example presentations: Benefit of establishing multidisciplinary diabetic foot clinics
2. Set-up: Discussion on best practices and pitfalls within diabetic foot care
3. Patient flow: Understanding patient pathways within mutidisciplinary care units
4. Treatment algorithm: Dos and don’ts
Wednesday, January 23rd: 15:30 - 16:30, Room 4 - Discussion Forum

CICE@LINC: Parallel grafts in the real world

Moderator:

Armando Lobato

Discussant:

Jan Brunkwall, Mario Lachat, Joao Gualberto Diniz, Ralf Kolvenbach, Konstantinos Donas
1. How to prevent gutter endoleaks with arch chimney grafts
2. Parallel grafts work well to treat aortic lesions involving the visceral segment and the arch: The mid- and long-term results demonstrate durability although re-interventions may be required
3. Three or four chimneys: Is it too much?
4. How Onyx can eliminate gutter endoleaks after parallel grafts used in AAA repairs: When to fix and technical tips
5. New findings from the PERICLES registry shed light on ways to improve outcomes of parallel grafts to treat complex aneurysms
6. Sandwich technique for treating complex aortoiliac aneurysms: Experience with 151 hypogastric revascularisations: lessons learned
Thursday, January 24th: 10:00 - 11:00, Room 4 - Discussion Forum

Vascular discussion: indications & evidence based therapies

sponsored by Medtronic

Moderator:

Giovanni Torsello
1. 10:00 - 10:15
  
  Unparalleled clinical data outcome from one AAA device and expanded treatment options with approval
2. 10:15 - 10:30
  
  Early endoluminal treatment in venous ulceration
3. 10:30 - 10:45
  
  Clinical evidence of IN.PACT and opportunities of DAART for the treatment of PAD
4. 10:45 - 11:00
  
  Clinical evidence of ONYX for the treatment of endoleakages and AVM's
Thursday, January 24th: 11:15 - 12:15, Room 4 - Discussion Forum

Vessel preparation: What is it and how to achieve best results?

Moderator:

Brian DeRubertis, Steven Kum

Discussant:

Aloke Finn, Konstantinos Donas, John Phillips
1. Vessel preparation with plain balloons – the role of sizing and dilatation time
2. Scoring balloons and high pressure dilatation with non-compliant balloons – How I do it
3. Vascular calcification in peripheral arteries: Implications for device design and procedural success
4. The use of orbital atherectomy and Intravascular Lithotripsy in fem-pop disease – What is the concept and how to best select the cases?
5. Directional atherectomy – what is the best technique and how to avoid complications?
6. The importance of vessel preparation prior to stenting
Thursday, January 24th: 15:00 - 16:00, Room 4 - Discussion Forum

VIVA@LINC: Strategies on the frontline – Illustrative cases with step-by-step approach – Venous disease, unsolved problems, and opportunities

Moderator:

John Laird

Discussant:

Chris Metzger, Sean Lyden, Gerard O'Sullivan
1. State-of-the-art in deep venous stenting
2. Vena cava filters – how to optimize treatment strategy
3. Trends in managing massive and submassive pulmonary embolus: How to intervene
4. Managing acute DVT: which tool to use and why and how to combine them
5. This is a topic-based session with illustrative cases. The speaker will present a recent case and go through a step-by-step approach with technical tips and advice on best management.

Room 5 - Global Expert Exchange

13 events

Tuesday, January 22nd: 10:30 - 12:00, Room 5 - Global Expert Exchange

CLI-Therapies-LINCed: Multidisciplinary case studies from centres of excellence. Tailored strategies on revascularisation and wound management

Moderator:

Steven Kum

Panel:

Yann Gouëffic, Yoshimitsu Soga, Marco Manzi, Roberto Ferraresi
1. MANAGING THE INFECTED WOUND
2. 10:30 - 10:42
  
  Case presentation: How do I combine wound care with revascularisation?
3. 10:42 - 10:45
  
  Question and answers
4. MULTI-VESSEL OR SINGLE VESSEL REVASCULARISATION
5. 10:45 - 10:57
  
  Case presentation: Why I chose multi vessel revascularisation
6. 10:57 - 11:00
  
  Question and answers
7. SIMULTANEOUS REVASCULARISATION AND WOUND CARE
8. 11:00 - 11:12
  
  Case presentation: Revascularisation and wound care under a nerve block – How to do it
9. 11:12 - 11:15
  
  Question and answers
10. OPTIMIZING THE “IN-FLOW” IN CLI
11. 11:15 - 11:27
  
  Case presentation: The use of DES in CLI
12. 11:27 - 11:30
  
  Question and answers
13. SOLUTIONS FOR POOR “OUTFLOW”
14. 11:30 - 11:42
  
  Case presentation: LimFlow procedure for no-option CLI
15. 11:42 - 11:45
  
  Question and answers
16. 11:45 - 12:00
  
  Panel round-up
Tuesday, January 22nd: 13:30 - 15:30, Room 5 - Global Expert Exchange

Latest advancements in diabetic patients: May drug elution technologies improve clinical outcome?

partially supported with an educational grant from Alvimedica

Moderator:

Roberto Ferraresi, Katja Mühlberg

Panel:

Marco Manzi, Giancarlo Biamino, Michael Edmonds, Eric Ducasse
1. 13:30 - 14:00
  
  Live case transmission from Bergamo
2. 14:00 - 14:06
  
  The distribution and management of peripheral arterial disease (PAD) in the diabetic patient with neuropathic (Charcot) arthropathy: a new paradigm of critical limb ischaemia in diabetes
3. 14:06 - 14:12
  
  Ischemia/infection/amputation: When, what, and how to intervene
4. 14:12 - 14:18
  
  Critical Limb Ischemia: time is crucial!
5. 14:18 - 14:24
  
  Endovascular intervention vs. open surgery: Pro/cons and boundaries
6. FOCUS ON SFA
7. 14:24 - 14:30
  
  Current developments in drug eluting technologies for complex SFA treatment
8. 14:30 - 14:36
  
  When should we use DCBs? Why?
9. 14:36 - 14:42
  
  When should we use DESs? Why?
10. FOCUS ON BTK
11. 14:42 - 14:48
  
  Which revascularisation strategy for BTK disease in DM patients? Wound-related or total treatment?
12. 14:48 - 14:54
  
  When should we use DCBs? Why?
13. 14:54 - 15:00
  
  When should we use DESs? Why?
14. 15:00 - 15:30
  
  Live case transmission from Berlin
Tuesday, January 22nd: 15:30 - 17:00, Room 5 - Global Expert Exchange

CCT@LINC: Advanced endovascular therapy in Japan – Pre-recorded live cases

Moderator:

Giancarlo Biamino, Kazushi Urasawa

Panel:

Michinao Tan, Tatsuya Nakama, Hiroshi Ando
1. 15:30 - 15:45
  
  Video live and lecture: EVT for SFA in-stent reocclusion
2. 15:45 - 16:00
  
  Video live and lecture: Aggressive below-the-ankle revascularisation
3. 16:00 - 16:15
  
  Video live and lecture: Techniques for severely calcified lesions
4. 16:15 - 16:30
  
  Video live and lecture: Optimization of POBA for DCB
5. 16:30 - 17:00
  
  Discussion and conclusion
Wednesday, January 23rd: 8:00 - 9:45, Room 5 - Global Expert Exchange

Lower limb interventions (part I) – Focus on latest information on drug-coated balloons

Moderator:

William Gray, Koen Deloose

Panel:

Juan Fernando Granada Solis, Aloke Finn, Eugenio Stabile
1. 08:00 - 08:25
  
  Live case transmission from Leipzig
2. 08:25 - 08:30
  
  Pre-clinical and histology findings from different DCBs
3. 08:30 - 08:35
  
  First time data release: A mechanistic look at 0.018 DCBs: Considerations for efficacy and durability of response
4. 08:35 - 08:40
  
  How DCB drug dose effects vessel healing
5. 08:40 - 08:45
  
  1-year outcome of the KANSHAS 1 study of the novel KANSHAS drug-coated balloon for treatment of femoropopliteal occlusive disease: the first-in-human study
6. 08:45 - 08:50
  
  Total IN.PACT 1-year results: Clinical outcomes from All-Comers
7. 08:50 - 08:55
  
  Total IN.PACT 1-year results: Imaging and propensity analysis
8. 08:55 - 09:00
  
  6 months SFA results from Levant Japan
9. 09:00 - 09:05
  
  Outcomes of DCB use in real world patients: 3-year clinical outcomes from the IN.PACT global study
10. 09:05 - 09:10
  
  Ranger DCB SFA registry: 24-month full cohort analysis
11. 09:10 - 09:15
  
  Long term results from the LegDeb registry
12. 09:15 - 09:20
  
  Cost economic evidence: what do DCB deserve? The US case example
13. 09:20 - 09:25
  
  Adverse effects of Paclitaxel on arterial pathology: Are we using the right drug on our DCBs?
14. 09:25 - 09:30
  
  12 months data from the EFFPAC randomized clinical trial
15. 09:30 - 09:45
  
  Discussion and conclusion
Wednesday, January 23rd: 9:45 - 10:45, Room 5 - Global Expert Exchange

JET@LINC

Moderator:

Giancarlo Biamino, Kazushi Urasawa, Hiroyoshi Yokoi

Panel:

Michinao Tan, Tatsuya Nakama, Masahiko Fujihara, Daizo Kawasaki, Osamu Iida
1. 09:45 - 09:50
  
  Introduction
2. 09:50 - 09:58
  
  A review of revascularisation techniques for femoropopliteal occlusions in Japan
3. 09:58 - 10:06
  
  The efficacy of pedal artery revascularisation; the final frontier of lower limbs intervention
4. 10:06 - 10:14
  
  The reconsideration of evaluation for complex SFA disease by the multidisciplinary modalities
5. 10:14 - 10:22
  
  IVUS guided intraluminal wiring for peripheral CTO lesion
6. 10:22 - 10:30
  
  Overview of CLI treatment evidence vs. experience
7. 10:30 - 10:45
  
  Discussion and conclusion
Wednesday, January 23rd: 10:45 - 12:30, Room 5 - Global Expert Exchange

Deep dive session: Lower limb interventions (part II) – Focus optimization of DCB-results in complex lesions, critical limb ischemia, and new implants

Moderator:

Iris Baumgartner-Peuker, Nicolas Shammas

Panel:

Stephan Duda, Marc Bosiers
1. 10:45 - 10:50
  
  IN.PACT DCB outcomes in CLI patients
2. 10:50 - 10:55
  
  Long-term durability and safety of DCB treatment in the SFA: Final 5-year clinical outcomes from the IN.PACT SFA trial
3. 10:55 - 11:00
  
  Changing paradigm: The role of DCB in Japanese clinical practice
4. 11:00 - 11:20
  
  Live case transmission from Leipzig
5. 11:20 - 11:25
  
  Dissections matter: Evidence for post PTA dissections
6. 11:25 - 11:30
  
  Dissection identification and classification using IVUS
7. 11:30 - 11:35
  
  Tack endovascular system – how I will use the Tack Endovascular System® in the real world
8. 11:35 - 11:40
  
  Impact of “Super Slow Inflation” as a lesion preparation in the DCB era
9. 11:40 - 11:45
  
  BIOLUX 4 EVER: Combining Passeo-18 Lux DCB and Pulsar-18 BMS – 24-month results of full cohort
10. 11:45 - 11:50
  
  Results from the 100 patients of the prospective TIGRIS Vienna study – update
11. 11:50 - 11:55
  
  The EVOLUTION study: a physician-initiated study investigating the iVolution stent in femoropopliteal lesions (final 24-month results)
12. 11:55 - 12:00
  
  BATTLE trial: RCT comparing BMS (Misago) vs. DES (Zilver PTX) for SFA intermediate lesions
13. 12:00 - 12:05
  
  Insights from the IMPERIAL trial
14. 12:05 - 12:10
  
  The usefulness of Zilver PTX for the treatment of in-stent restenosis of the superficial femoral artery
15. 12:10 - 12:15
  
  Outcomes of Paclitaxel coated technology in treating patients with Rutherford 5 and 6 peripheral arterial disease
16. 12:15 - 12:20
  
  Economic evaluation of IN.PACT Admiral drug-coated balloon (DCB) for treatment of CLI lesions of the SFA, in the Dutch healthcare system
17. 12:20 - 12:30
  
  Discussion and conclusion
Wednesday, January 23rd: 12:30 - 13:30, Room 5 - Global Expert Exchange

Lunch symposium: It’s time to unwind! Accelerating thrombus dissolution with EKOS™ acoustic pulse thrombolysis in everyday clinical practice

supported with an educational grant from BTG

Moderator:

Nils Kucher

Panel:

Houman Jalaie, Mert Dumantepe
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:50
  
  Risk stratification of acute PE: Selection of patients for catheter intervention
3. 12:50 - 13:05
  
  5-year follow up for acute DVT patients treated with EKOS™: experience from Aachen University Hospital
4. 13:05 - 13:20
  
  Treatment of chronic DVT with EKOS: reproducing ACCESS PTS data in every day clinical practice
5. 13:20 - 13:30
  
  Discussion and conclusion
Wednesday, January 23rd: 13:30 - 14:30, Room 5 - Global Expert Exchange

CCT@LINC – Various techniques to recanalise CTO

Moderator:

Ralf Langhoff, Hiroshi Ando

Panel:

Michinao Tan, Tatsuya Nakama, Kazushi Urasawa
1. 13:30 - 13:43
  
  Video live and lecture: Gachon technique for non-removable thrombus
2. 13:43 - 13:56
  
  Video live and lecture: Various distal puncture techniques
3. 13:56 - 14:09
  
  Video live and lecture: Trans-collateral wiring
4. 14:09 - 14:22
  
  Video live and lecture: Needle clucking technique
5. 14:22 - 14:30
  
  Discussion and conclusion
Wednesday, January 23rd: 14:30 - 15:50, Room 5 - Global Expert Exchange

Deep dive session: Endovenous therapies (part I)

Moderator:

Nils Kucher, Gerard O'Sullivan

Panel:

Robert Lookstein, Rick de Graaf, Rupert Bauersachs
1. FOCUS ON ACUTE DVT
2. 14:30 - 14:37
  
  Evidence on mechanical thrombectomy for iliofemoral DVT: Latest trial update
3. 14:37 - 14:44
  
  Single center registry for the treatment of acute deep venous thrombosis by Angiojet
4. 14:44 - 14:51
  
  1-year outcomes of the Indigo thrombectomy catheter for deep vein thrombosis
5. 14:51 - 14:58
  
  Catheter-directed thrombolysis vs. mechanical thrombectomy in Ilio femoral DVT. Why I choose one over the other
6. FOCUS ON CHRONIC DVT, DEEP VEIN RECANALISATION, AND STENTING
7. 14:58 - 15:05
  
  Venous stenting: May Thurners, a patient story
8. 15:05 - 15:12
  
  LINC status update: The role of venous stenting in the absence of clear scientific data – Medical therapy is ususally enough
9. 15:12 - 15:19
  
  No, I see the quality and necessity for stenting
10. 15:19 - 15:26
  
  New strategy for endovascular treatment of the obstructed common femoral vein
11. 15:26 - 15:33
  
  The VIDIO trial: diagnostic and clinical implications on the use of IVUS for deep venous treatment
12. 15:33 - 15:40
  
  How common is iliac vein rupture during venous reconstruction and what to do?
13. 15:40 - 15:50
  
  Discussion and conclusion
Wednesday, January 23rd: 15:50 - 16:50, Room 5 - Global Expert Exchange

Deep dive session: Endovenous therapies (part II)

Moderator:

Tobias Hirsch

Panel:

Michel Reijnen, Matthias Ulrich, Karin Brachmann
1. FOCUS ON SUPERFICIAL FEMORAL DISEASE
2. 15:50 - 15:57
  
  LINC to phlebology – what’s new in endovenous varicose vein treatment?
3. 15:57 - 16:04
  
  Long-term experience with the Clarivein technology
4. 16:04 - 16:11
  
  Advantages and pitfalls of endovenous glue for varicose vein treatment
5. 16:11 - 16:18
  
  Venous ulcer care – What we know and what we don’t
6. 16:18 - 16:25
  
  Foam – short track to ulcer healing
7. 16:25 - 16:32
  
  The new Sclero Safe Endovenous device for varicose vein treatment
8. 16:32 - 16:50
  
  Discussion and conclusion
Thursday, January 24th: 9:00 - 11:00, Room 5 - Global Expert Exchange

Global expert exchange: Selected challenging cases – PVD

Moderator:

Giancarlo Biamino, Ramon Varcoe

Panel:

Peter Huppert
1. 09:00 - 09:05
  
  A case of Leriche syndrome after axillo-femoral bypass failure which was difficult to distal embolism
2. 09:05 - 09:10
  
  Bilateral iliac artery intervention in Takayasu’s arteritis
3. 09:10 - 09:15
  
  Pieces and parts: Use of the Gore Excluder, Iliac Branched Endoprosthesis, and VBX balloon expandable stent grafts for the treatment of aorto-iliac occlusive disease
4. 09:15 - 09:20
  
  The effect of directional atherectomy +DCB in TASC C&D femoro-popliteal lesions
5. 09:20 - 09:25
  
  Could we use atherectomy device at common femoral artery
6. 09:25 - 09:30
  
  Endovascular interventions after open surgery of the arteries of the lower extremities
7. 09:30 - 09:35
  
  Comparison of Angiographic dissection patterns caused by Long vs. short balloons during balloon angioplasty for chronic femoropopliteal occlusions
8. 09:35 - 09:40
  
  Complex intervention to a chronic totally occluded TP Trunk and peroneal artery, with intervention to the popliteal artery and SFA requiring supera placement
9. 09:40 - 09:45
  
  Use of adjunct laser therapy for the treatment of femoropopliteal instent restenosis – A safety and efficacy analysis
10. 09:45 - 09:50
  
  Unique treatment of popliteal aneurysm with kissing interwoven nitinol stents
11. 09:50 - 09:55
  
  RECROSS technique: revascularisation by crushing chronically occluded stents
12. 09:55 - 10:00
  
  Endovascular management of traumatic vascular injury in lower extremities
13. 10:00 - 10:05
  
  Modern lower extremity revascularisation: adapting skill sets from dialysis access thrombectomy
14. 10:05 - 10:10
  
  Argentinean registry for endovascular treatment in lower limbs “RAdAMI”
15. 10:10 - 10:15
  
  The trials and tribulations of hawking in the tibials
16. 10:15 - 10:20
  
  Strategy of EVT for calcified below-the-knee lesions in our hospital
17. 10:20 - 10:25
  
  Limb salvage at all costs: How do you leverage all of the tools in your tool box
18. 10:25 - 11:00
  
  Discussion and conclusion
Thursday, January 24th: 11:00 - 12:30, Room 5 - Global Expert Exchange

Special course for nurses, technicians, and fellows: Current concepts and new approaches in endovascular interventions – Step-by-step review of techniques and data by leading interventional experts

Moderator:

Ulf Teichgräber, Tilo Kölbel
1. FOCUS ON CAROTID STENTING AND EMBOLIZATION THERAPIES
2. 11:00 - 11:08
  
  Carotid artery stenosis – diagnostic approach and indication for treatment
3. 11:08 - 11:16
  
  Carotid artery stenting – latest technologies
4. 11:16 - 11:24
  
  Principles of coil embolization for bleeding, endoleaks, and beyond
5. 11:24 - 11:32
  
  Interventional tumor therapy: what is available and how does it work?
6. 11:32 - 11:40
  
  New applications for embolization therapies
7. FOCUS ON ENDOVASCULAR AORTIC REPAIR
8. 11:40 - 11:48
  
  Endovascular aortic repair of infrarenal aortic and iliac aneurysms – from imaging to implantation
9. 11:48 - 11:56
  
  The role of 2D and 3D fusion imaging for reconstruction of complex aortic pathologies
10. 11:56 - 12:04
  
  Branched and fenestrated grafts – When and how to use?
11. 12:04 - 12:12
  
  Endovascular treatment of aortic dissections
12. 12:12 - 12:20
  
  Glimpse into the future: Endovascular treatment of the aortic arch and the ascending aorta
13. 12:20 - 12:28
  
  The percutaneous approach: What do we need to know about different access sites?
14. 12:28 - 12:30
  
  Discussion and conclusion
Thursday, January 24th: 13:30 - 15:00, Room 5 - Global Expert Exchange

Special course for nurses, technicians, and fellows: Current concepts and new approaches in endovascular interventions – Step-by-step review of techniques and data by leading interventional experts

Moderator:

Sabine Steiner, Martin Werner
1. FOCUS ON PERIPHERAL ARTERIAL INTERVENTIONS
2. 13:30 - 13:38
  
  New approaches to measure perfusion after recanalisation in CLI procedures
3. 13:38 - 13:46
  
  A review of atherectomy devices: What works best in which lesion
4. 13:46 - 13:54
  
  Radiaton protection – what is new
5. 13:54 - 14:02
  
  Latest data in the field of drug-eluting therapies: What is the current status?
6. 14:02 - 14:10
  
  The retrograde approach – when and how to do it
7. 14:10 - 14:18
  
  What is Intravascular Lithotripsy and when to use it
8. 14:18 - 14:26
  
  New hope for end-stage CLI patients: The concept of deep venous arterialization
9. FOCUS ON VENOUS INTERVENTIONS AND AV-ACCESS
10. 14:26 - 14:34
  
  Iliac vein recanalisations: Indication, techniques, and outcome
11. 14:34 - 14:42
  
  Endoluminal treatment of varicose veins
12. 14:42 - 14:50
  
  Percutaneous creation of AV-fistula – initial experience
13. 14:50 - 15:00
  
  Discussion and conclusion

Room 6 - Speakers' corner

11 events

Tuesday, January 22nd: 12:30 - 13:30, Room 6 - Speakers' corner

Update on clinical trials and new data – PVD/BTK/CLI

Moderator:

Jihad Mustapha

Panel:

Matthew Menard, Miguel Montero-Baker
1. 12:30 - 12:35
  
  Magnesium resorbable drug-eluting scaffold (Magmaris) for below the knee recanalisation: 12-months follow-up analysis
2. 12:35 - 12:40
  
  Clinical effectiveness of the absorb bioresorbable vascular scaffold in patients with complex infrapopliteal arterial disease
3. 12:40 - 12:45
  
  24-months outcomes of patients presenting with critical limb ischemia within the BIOLUX P-III registry – a real-world clinical trial treating atheriosclerotic arteries with a paclitaxel covered balloon
4. 12:45 - 12:50
  
  Angioplasty and stenting versus bypass graft surgery for the treatment of simultaneous femoropopliteal and infrapopliteal complex (TASC C or D) arterial disease in patients with critical limb ischemia
5. 12:50 - 12:55
  
  Impact of endovascular pedal arch reconstruction on wound healing in patients with critical limb ischemia
6. 12:55 - 13:00
  
  Impact of wound ischemia and foot infection (WIfI) stage as an independent predictor of limb salvage in revascularised threatened limb ischemia
7. 13:00 - 13:05
  
  Wound blush as a prognostic factor for limb salvage in diabetic patients with ischemic tissue loss after successful endovascular treatment
8. 13:05 - 13:10
  
  Comparison between surgical and endovascular infrapopliteal limb revascularisation at a terciary cardiovascular care center
9. 13:10 - 13:30
  
  Discussion
Tuesday, January 22nd: 13:30 - 15:00, Room 6 - Speakers' corner

Update on clinical trials and new data – PVD/SFA

Moderator:

Iris Baumgartner-Peuker

Panel:

William Gray
1. 13:30 - 13:35
  
  Peripheral CTO crossing with the SoundBite™ active wire
2. 13:35 - 13:40
  
  Safety and feasibility of intravascular lithotripsy for treatment of common femoral artery stenoses
3. 13:40 - 13:45
  
  EffPac-Trial: Effectiveness of LUMINOR® DCB vs. POBA in the SFA: primary endpoint and 12-months results
4. 13:45 - 13:50
  
  Diabetic patients in a real-world clinical trial treated for peripheral arterial disease with a paclitaxel covered balloon. 24-month results of the BIOLUX P-III All Comers Registry
5. 13:50 - 13:55
  
  BEnefit of arterial preparation by LONGitudinal scoring before paclitaxel eluting balloon angioplasty of the superficial femoral and popliteal artery (The BELONG Study): recruitment status and early results
6. 13:55 - 14:00
  
  Subgroup analyses of the CONSEQUENT randomized controlled trial investigating the clinical benefits of paclitaxel-resveratrol coated balloon angioplasty
7. 14:00 - 14:05
  
  Outcome of DEB and PTA post stenting in occluded vs. stenotic lesions – subgroup analysis of the randomized Freeway Stent study
8. 14:05 - 14:10
  
  Novel laser-based atherectomy catheter. Results from the Eximo Medical B-Laser™ IDE study
9. 14:10 - 14:15
  
  24-month outcomes in the EVOLUTION study: Investigating the iVolution stent in femoropopliteal lesions
10. 14:15 - 14:20
  
  Bi-directional, self-expanding stent for superficial femoral artery lesions – 2-year interim-results from the Q3 registry
11. 14:20 - 14:25
  
  A real world comparison of interwoven nitinol (Supera®) with drug-eluting stent (Zilver® PTX®) in patients with symptomatic femoro-popliteal stenosis
12. 14:25 - 14:30
  
  2-years results of a pilot prospective randomized study of the effect of dissection of the lamina vastoadductoria after stenting of the superficial femoral artery on the incidence of restenosis and stent fractures in TASC-II D lesions of the femoropopliteal arterial segment
13. 14:30 - 14:35
  
  Results from the ENTRAP study: Lower extremity intervention using the Vanguard® IEP peripheral balloon angioplasty system with integrated embolic protection
14. 14:35 - 14:40
  
  Two year mortality post DEB and plain balloon angioplasty: pooled primary data analysis of 4 RCTs
15. 14:40 - 15:00
  
  Discussion
Tuesday, January 22nd: 15:00 - 16:30, Room 6 - Speakers' corner

Update on clinical trials and new data – PVD/carotid/venous/AV access/EVAR

Moderator:

Stephan Duda

Panel:

Jean-Paul de Vries, Peter Huppert
1. 15:00 - 15:05
  
  PrOspective multiCentrE study of cArotid artery steNting using MER stent– the OCEANUS study – 30 days and one year follow-up
2. 15:05 - 15:10
  
  PARADIGM-EXTEND prospective academic trial of CGuard™ MicroNET-covered self-expandable stent system: Cumulative 3-year clinical and duplex ultrasound evidence for safety, efficacy, and durability of stroke prevention
3. 15:10 - 15:15
  
  Double layer micromesh stents vs. closed cell stents for the endovascular treatment of carotid stenosis in the current era
4. 15:15 - 15:20
  
  Intermediate results of a prospective randomized study in carotid artery revascularisation: the Acculink™ stent vs. the mesh covered stent (CGuard™)
5. 15:20 - 15:25
  
  Ad interim results from a prospective real-world multicentre clinical practice of CAS using the CGuard™ embolic prevention system: the IRONGUARD 2 study
6. 15:25 - 15:30
  
  Significant contrast dose-reduction with digital variance angiography in carotid and cerebral X-ray angiography
7. 15:30 - 15:35
  
  Comparative analysis of carotid artery stenting and carotid endarterectomy in clinical practice
8. 15:35 - 15:40
  
  Clinical evaluation on therapeutic efficacy of Angiojet Rheolytic thrombectomy in patients with acute pulmonary embolism
9. 15:40 - 15:45
  
  Significant reduction in radiation using the 4 French instead of 6 French WavelinQ endoAVF system in creating endovascular AV-fistulas
10. 15:45 - 15:50
  
  Fully absorbable patch based large hole vascular closure device
11. 15:50 - 15:55
  
  2-year outcomes of EVAS and Ch-EVAS in abdominal aortic aneurysms based on calculated neck length: a single-center study
12. 15:55 - 16:00
  
  Interim results from the PERFORMANCE I study – CAS using a 3-in-1 carotid artery stent system with an integrated embolic protection filter and post-dilation balloon
13. 16:00 - 16:30
  
  Discussion
Wednesday, January 23rd: 9:00 - 11:00, Room 6 - Speakers' corner

Selected abstracts challenging cases – venous/AV

Moderator:

Rick de Graaf

Panel:

Sebastian Sixt, Bruno Freitas
1. 09:00 - 09:05
  
  Aspiration thrombectomy for acute deep vein thrombosis of the left lower extremity of a child after cardiac radiofrequency ablation
2. 09:05 - 09:10
  
  Mortality case after stent placement for SVC syndrome
3. 09:10 - 09:15
  
  Bilateral breast enlargement: an unusual presentation of SVC obstruction in a hemodialysis patient with fibrosing mediastinitis
4. 09:15 - 09:20
  
  Emergency single stage superior vena cava and pulmonary artery stenting
5. 09:20 - 09:25
  
  Catastrophic antiphospholipid syndrome complicated with hepatic budd chiari syndrome and inferior vena cava occlusion: case report of successful management with endovascular sharp IVC recanalisation and direct intrahepatic porto-systemic shunting
6. 09:25 - 09:30
  
  Endovascular treatment for IVC filter related PTS
7. 09:30 - 09:35
  
  Endovascular treatment of traumatic intra-abdominal suprahepatic IVC rupture
8. 09:35 - 09:40
  
  Catheter directed thrombolysis followed by PTA of superior vena cava in a patient with severe SVC syndrome 3 years post PPM
9. 09:40 - 09:45
  
  Right ovarian vein syndrome
10. 09:45 - 09:55
  
  Discussion
11. 09:55 - 10:00
  
  Endovascular management of concurrent ilio-iliac arteriovenous fistula and ipsilateral common iliac vein occlusion
12. 10:00 - 10:05
  
  Successful percutaneous management of massive active bleeding from the ulcerated skin in two cases of complex AVM
13. 10:05 - 10:10
  
  Postraumatic high-flow priapism treated with superselective arterial coil embolization: case report and literature review
14. 10:10 - 10:15
  
  Sharp recanalisation of central venous occlusion utilizing re-entry catheter
15. 10:15 - 10:20
  
  Inferior vena caval obstruction and limited role of endovenous therapy
16. 10:20 - 10:25
  
  Duodenal perforation consequent to a cava filter migration
17. 10:25 - 10:30
  
  Klippel Trenaunay syndrome. When and what to do?
18. 10:30 - 10:35
  
  Advanced stage metastatic prostatic adenocarcinoma causing bilateral extensive Ilio-femoral DVT & infra-renal IVC thrombosis
19. 10:35 - 10:40
  
  Single session combined treatment of acute pulmonary embolism (PE) and acute deep venous thrombosis (DVT) with mechanical aspiration thrombectomy: single center experience
20. 10:40 - 11:00
  
  Discussion and conclusion
Wednesday, January 23rd: 11:00 - 11:30, Room 6 - Speakers' corner

Selected abstracts challenging cases – AV access related issues

Moderator:

Konstantinos Katsanos

Panel:

Robert Jones
1. 11:00 - 11:05
  
  Durability and cost effectiveness of peripheral inserted portcath for chemotherapy
2. 11:05 - 11:10
  
  Central venous occlusive disease in hemodialysis patients. What to do when the dialysis fistula is quickly occluded after reintervention?
3. 11:10 - 11:15
  
  Dialysis access endovascular interventions and strategies for reducting hematomas with perforation
4. 11:15 - 11:20
  
  Extreme hemodialysis access: a transhepatic HeRO
5. 11:20 - 11:25
  
  IN.PACT Admiral DCB In upper limb arteriovenous fistulae/graft. A South African single unit audit
6. 11:25 - 11:30
  
  Lessons learned from 257 patients treated by surgical correction of dialysis steal syndrome
Wednesday, January 23rd: 11:30 - 12:30, Room 6 - Speakers' corner

GDPR in a clinical setting

Moderator:

Ulrich Beschorner, Aly Talen
1. 11:30 - 11:38
  
  GDPR: What's all the fuss about?
2. 11:38 - 11:46
  
  New PIC-requirements by GDPR: The EC's view
3. 11:46 - 11:54
  
  What do EU hospitals need to comply with GDPR in medical studies
4. 11:54 - 12:02
  
  MD perspective: what changed? How does GDPR affect communication with the patient?
5. 12:02 - 12:10
  
  GDPR requirements for non-EU based manufacturers
6. 12:10 - 12:30
  
  Discussion and conclusion
Wednesday, January 23rd: 12:30 - 13:35, Room 6 - Speakers' corner

Challenging cases and complications – EVAR aortic dissections

Moderator:

Vicente Riambau

Panel:

Fabio Verzini
1. 12:30 - 12:35
  
  Aortic dissection repair using the stabilise technique associated to arch procedures. Report of two cases
2. 12:35 - 12:40
  
  Endovascular and open rescue interventions in a case of inadvertent false lumen stentgraft implantation
3. 12:40 - 12:45
  
  Endoanchores to stabilize short distal landing zone in challenged large thoracic aneurysm
4. 12:45 - 12:50
  
  Complex multi-staged hybrid treatment in case of a complicated Type B dynamic dissection
5. 12:50 - 12:55
  
  Trans-apical endovascular repair of Iatrogenic Type A aortic dissection: 5-year follow-up results
6. 12:55 - 13:00
  
  Dissection flap as bailout navigator with reversed petticoat technique in complicated acute Type B aortic dissection (case presentation)
7. 13:00 - 13:05
  
  IVUS guidance to gain collapsed true lumen in a complicated acute Type B dissection
8. 13:05 - 13:10
  
  Percutaneous balloon fenestration and stent placement for lower limb ischemia complicated with Type B aortic dissection: An 8-year follow up
9. 13:10 - 13:15
  
  Hybrid procedure for a young patient with Type B aortic dissection and malperfusion syndrome
10. 13:15 - 13:20
  
  Ortner’s syndrome secondary to penetrating aortic arch ulcer treated with TEVAR
11. 13:20 - 13:25
  
  Effects of false lumen procedures for chronic DeBakey Type IIIb aortic dissection
12. 13:25 - 13:30
  
  A complex case of penetrating aortic ulcer in a young man
13. 13:30 - 13:35
  
  Cheese-wire fenestration to create a suitable landing zone for treatment of complex aortic dissection with late aneurysm formation
Wednesday, January 23rd: 14:00 - 15:15, Room 6 - Speakers' corner

Challenging cases and complications – EVAR thoracic aorta/aortic arch/thoracoabdominal aneurysms

Moderator:

Martin Malina

Panel:

Chang Shu, Frank Criado
1. 14:00 - 14:05
  
  Initial single-center experience with the use of the Covera Plus covered stent in combination with the Colt device in complex aortic repair
2. 14:05 - 14:10
  
  Multilayer flow modulator placement for peri-visceral saccular aneurysm with hemodynamic evaluation with AneurysmFlowSM: A case report
3. 14:10 - 14:15
  
  Congenital anomalies of the aortic arch; are they so rare?
4. 14:15 - 14:20
  
  Use of parallel stents in visceral arteries in giant aneurisma with challenger neck: Case report
5. 14:20 - 14:25
  
  Management of T-Branch infection
6. 14:25 - 14:30
  
  Thoracic wall sternal reconstruction tilted implant perforating the ascending aorta: endovascular repair with ascending TEVAR
7. 14:30 - 14:35
  
  Complete De-Branching aortic arch, with TEVAR from ascending aorta
8. 14:35 - 14:40
  
  Total arch replacement with chimney endovascular technique
9. 14:40 - 14:45
  
  Successful treatment of post-traumatic arch pseudoaneurysm with fenestrated custom-made TEVAR
10. 14:45 - 14:50
  
  Cervical aortic arch debranching with laser fenestration of TEVAR for ascending/aortic arch pathology
11. 14:50 - 14:55
  
  Staged open and endovascular management of the entire aorta in a patient with complicated Type A dissection
12. 14:55 - 15:00
  
  Iliac artery rupture during endovascular repair of the thoracic aorta
13. 15:00 - 15:15
  
  Discussion
Thursday, January 24th: 10:30 - 12:30, Room 6 - Speakers' corner

Challenging cases and complications – PVD femoral/BTK

Moderator:

Sean Lyden

Panel:

Jörn Balzer
1. 10:30 - 10:35
  
  Percutaneous mechanical stent thrombectomy used as therapy for acute limb ischemia
2. 10:35 - 10:40
  
  Treatment of calcified common and superficial femoral artery stenoses with retrograde atherectomy and dcb under protection of antegradely delivered anti-embolic filter in a patient with kissing iliac stents
3. 10:40 - 10:45
  
  Body flossing technique the extremely helpful option
4. 10:45 - 10:50
  
  How to use a wire to capture a missed wire?
5. 10:50 - 10:55
  
  Zero-contract atherectomy of femoropopliteal lesions
6. 10:55 - 11:00
  
  Novel approach to popliteal occlusive disease
7. 11:00 - 11:05
  
  The combined use of an excimer laser and rotational atherectomy to overcome a severely calcified lesion bouncing any other devices back
8. 11:05 - 11:10
  
  Peripheral arteries hybrid surgery in high-risk patients
9. 11:10 - 11:15
  
  Midterm outcomes of percutaneous bypass for very long femoropopliteal occlusion
10. 11:15 - 11:20
  
  Endovascular treatment for critical lower limb ischemia caused by giant cell arteritis
11. 11:20 - 11:25
  
  Case report of persistant sciatic artery
12. 11:25 - 11:30
  
  A rare cause of angina after coronary bypass grafting; left internal mammary artery to pulmonary artery fistula and successful treatment with transcatheter coil embolization
13. 11:30 - 11:35
  
  Transcatheter arterial embolization for intercostal pseudoaneurysm, which was causing haemothorax after lobectomy
14. 11:35 - 11:40
  
  Retrieval of retained scoring balloon after angioplasty with endoscopic forceps: a case report of an elderly lady with below the knee angioplasty for critical limb ischaemia
15. 11:40 - 11:45
  
  Hand salvage through catheter directed thrombolysis with Inj.rt-PA (Reteplase & Heparin) and drug coated balloon angioplasty for atheromatous plaques
16. 11:45 - 11:50
  
  CLI and multilevel disease
17. 11:50 - 11:55
  
  Efficacy and safety of EVT by diluted contrast angioplasty for CKD patients
18. 11:55 - 12:00
  
  EKOS utilisation in a case of acute craft occlusion causing acute limb ischemia
19. 12:00 - 12:05
  
  Intentional wire manipulation with IVUS guidance is only reliable method for antegrade approach in CTO
20. 12:05 - 12:10
  
  Angiosome directed revascularization using drug eluting balloons and stents is safe and offers the best limb salvage rates
21. 12:10 - 12:15
  
  How to create a critical limb ischemia team to reduce amputation in underserved areas
22. 12:15 - 12:30
  
  Discussion and conclusion
Thursday, January 24th: 12:30 - 13:30, Room 6 - Speakers' corner

Innovation forum – PVD-general

Moderator:

George Adams

Panel:

Konstantinos Katsanos
1. 12:30 - 12:35
  
  Homemade device to facilitate wire threading of low profile catheters
2. 12:35 - 12:40
  
  Practical experience with the Renal Guard system
3. 12:40 - 12:45
  
  XO score: a novel scoring sheath for treatment of complex lesions and BTK CTOs
4. 12:45 - 12:50
  
  Real-time display of regions of interest with future event risk in angioscopic images using deep machine learning on mobile AI devices in patients with PAD
5. 12:50 - 12:55
  
  Impact of calcification modeling and planning circles with fusion imaging for the chronical total occlusion of iliac and femoro-popliteal arteries
6. 12:55 - 13:00
  
  A 3D gluteal artery model poured in silicone to facilitate gluteal artery puncture and training
7. 13:00 - 13:05
  
  Cell-based therapy for the treatment of diabetes mellitus by local intra-arterial delivery of autologous bone marrow-derived adult stem cells in the pancreas
8. 13:05 - 13:10
  
  A study on targeted delivery of platelet bioinspired liposome with rapamycin in the treatment of atherosclerosis
9. 13:10 - 13:30
  
  Discussion
Thursday, January 24th: 13:30 - 14:30, Room 6 - Speakers' corner

Innovation forum – PVD-SFA/BTK

Moderator:

Jihad Mustapha

Panel:

Miguel Montero-Baker
1. 13:30 - 13:35
  
  Totally percutaneous fem-pop bypass: the best of the two worlds
2. 13:35 - 13:40
  
  Next generation of DCB: Efficacy and tolerance of drug-coated hyper-compliant balloons (DCHCB) in peripheral arteries of swine
3. 13:40 - 13:45
  
  Vascular responses and drug transfer upon treatment with the Reflow Temporary Spur Stent System
4. 13:45 - 13:50
  
  Animal safety study for the SoundBite™ Active Wire
5. 13:50 - 13:55
  
  The results of a 40 patient cohort at a single center with the DABRA atherectomy system
6. 13:55 - 14:00
  
  Characterization of subcutaneous oxygen microsensors in healthy volunteers: in vivo evidence of a tool for future management of CLI patients
7. 14:00 - 14:05
  
  Intra-sensor analysis of subcutaneous oxygen microsensors reveal heterogenous reperfusion response during revascularisation procedures for CLI patients
8. 14:05 - 14:10
  
  Virtual partial foot amputation based on finite element analysis
9. 14:10 - 14:15
  
  Totally percutaneous deep foot veins arterialization. Single centre experience
10. 14:15 - 14:20
  
  New technique to facilitate percutaneous venous arterialization in patients with no-option critical limb ischemia
11. 14:20 - 14:30
  
  Discussion

Room 7 - Speakers' corner

10 events

Tuesday, January 22nd: 12:30 - 13:30, Room 7 - Speakers' corner

Selected abstracts original research – EVAR (part I)

Moderator:

Konstantinos Donas

Panel:

Sven Seifert, Thomas Larzon
1. 12:30 - 12:35
  
  Open thoracic and thoraco-abdominal aortic repair after prior endovascular therapy
2. 12:35 - 12:40
  
  The evolving management of ruptured abdominal aortic aneurysms: An Australasian experience
3. 12:40 - 12:45
  
  Results of Chimney EVAR as used in the PERICLES registry to treat patients with suprarenal aortic pathologies
4. 12:45 - 12:50
  
  Prevention of Type II endoleak: role of EVAS technique in comparison to sac embolization technique in case of abdominal aortic aneurysm treatment
5. 12:50 - 12:55
  
  Systematic multi-staged endovascular repair of thoracoabdominal aneurysms with fenestrated and branched endografts (STEAR study)
6. 12:55 - 13:00
  
  Screaning Cardiovascular patients for Aortic aNeurysms (SCAN) – High prevalence of AAA in CHD requiring intervention
7. 13:00 - 13:05
  
  Hypogastric revascularisation during EVAR: surgical and endovascular techniques. Single centre experience
8. 13:05 - 13:10
  
  The subclavian artery access for difficult vascular interventions
9. 13:10 - 13:15
  
  Impact of post-EVAR graft limb kinking in EVARlimb occlusion – etiology, early diagnosis, and management
10. 13:15 - 13:30
  
  Discussion
Tuesday, January 22nd: 13:30 - 15:00, Room 7 - Speakers' corner

Selected abstracts original research – EVAR (part II)

Moderator:

Giovanni Torsello

Panel:

Spiridon Botsios
1. 13:30 - 13:35
  
  Aortic dilatation following Type B aortic dissection: a single-center retrospective study
2. 13:35 - 13:40
  
  Endovascular therapy for ischemic vs. non-ischemic complicated acute Type B aortic dissection (cATBAD)
3. 13:40 - 13:45
  
  New off-the-shelf FEVAR technique
4. 13:45 - 13:50
  
  Feasibility of aortic neck anatomy for endovascular aneurysm repair in Korean patients with abdominal aortic aneurysm
5. 13:50 - 13:55
  
  Sequalae of EVAR limb occlusion, a 6 year retrospective review
6. 13:55 - 14:00
  
  Cardiovascular implications of post-implantation syndrome
7. 14:00 - 14:05
  
  Subclavian Artery Plug Embolization (SAPE study): a real experience about endovascular subclavian occlusion prior to thoracic vascular repair
8. 14:05 - 14:10
  
  Totally percutaneous access for thoracic and thoracoabdominal endovascular aortic repair: upper extremity access
9. 14:10 - 14:15
  
  Low risk of spinal cord ischemia after endovascular repair for juxtarenal and thoracoabdominal aortic aneurysms using parallel stent graft implantation
10. 14:15 - 14:20
  
  The Colt device – How cooperation with industry influenced the treatment of complex TAAAs
11. 14:20 - 14:25
  
  “Soft” hybrid procedures in high risk patients – new view of aortic arch aneurysm treatment
12. 14:25 - 14:30
  
  TEVAR performed in 106 year old female; advantage of low profile Zenith Alpha thoracic endovascular graft
13. 14:30 - 15:00
  
  Discussion
Wednesday, January 23rd: 8:30 - 9:30, Room 7 - Speakers' corner

Challenging cases and complications – iliac/embolization

Moderator:

Jörn Balzer

Panel:

Hans Krankenberg
1. 08:30 - 08:35
  
  Percutaneous trans-gluteal embolization of an internal iliac artery aneurysm in a case of occlude IBE
2. 08:35 - 08:40
  
  Endovascular therapy of aortoiliac occlusion – Could it be the first line therapy?
3. 08:40 - 08:45
  
  Bilateral common femoral artery endaterectomy with covered endovascular reconstruction of aortic bifurcation (CERAB) with retrograde left anterior tibial artery for PRESTO technique to conquer the complex aorto-iliac occlusive disease with heavily calcified CFA and long segment chronic total occlusion (CTO) lesion of SFA
4. 08:45 - 08:50
  
  Use of the transbrachial approach with regular radial sheath as an alternative method in the management of aortoiliac occlusive arterial diseases
5. 08:50 - 08:55
  
  Exclusion of a traumatic, giant arteriovenous fistula in a thirty-year-old female patient using endovascular technique
6. 08:55 - 09:00
  
  Endovascular treatment of ureteroarterial fistula using a covered stent, evaluated by intravascular ultrasound: A case report
7. 09:00 - 09:05
  
  Leriche syndrome percutaneous treatment in patient with CLI – CERAB technique modification with protection of inferior mesenteric artery
8. 09:05 - 09:10
  
  Combined thrombolysis, suction, and open aorto-iliac thrombectomy
9. 09:10 - 09:15
  
  Endovascular treatment of arterial complications after orthopedic surgery of the hip
10. 09:15 - 09:20
  
  Complex vascular complication after Hip TEP
11. 09:20 - 09:25
  
  Retrograde embolization of symptomatic hypogastric artery aneurysm
12. 09:25 - 09:30
  
  Unusual transarterial embolization for frozen shoulder in case of ulcerative colitis
Wednesday, January 23rd: 9:30 - 11:00, Room 7 - Speakers' corner

Challenging cases and complications – carotid/visceral/renal

Moderator:

Stanislaw Bartus

Panel:

Klaus Mathias
1. 09:30 - 09:35
  
  Internal carotid pseudoaneurysm treated with diverted flow stent
2. 09:35 - 09:40
  
  Traumatic subclavian pseudoaneurism treated by hybrid technique
3. 09:40 - 09:45
  
  Early endovascular approach in acute internal carotid artery dissection
4. 09:45 - 09:50
  
  Hybrid operation for a huge internal carotid arterial aneurysm
5. 09:50 - 09:55
  
  Dysphagia Lusoria due left subclavian Kommerell diverticulum
6. 09:55 - 10:00
  
  A case of successful EVT for acute hand ischemia with using trans collateral channel approach
7. 10:00 - 10:05
  
  Experience on management of extracranial carotid aneurysms
8. 10:05 - 10:10
  
  IVUS & OCT during CAS
9. 10:10 - 10:15
  
  Endovascular management of massive hemobilia due to cystic artery pseudoaneurysm following laproscopic cholecystectomy
10. 10:15 - 10:20
  
  Management of giant celiac artery aneurysm in a frail patient
11. 10:20 - 10:25
  
  Endovascular treatment of acute bleeding from a SMA pseudoaneurysm following pancreaticoduodenectomy by implantation of coronary stent-grafts
12. 10:25 - 10:30
  
  Covered stents for the treatment of renal artery in-stent restenosis (ISR). A viable option for a common problem. Case presentation and literature review
13. 10:30 - 10:35
  
  Complex interventions in abdominal aorta and its branches in children with Takayasu arteritis
14. 10:35 - 10:40
  
  Case study: complete occlusion of mesenteric vessels with vascularisation surgically
15. 10:40 - 11:00
  
  Discussion
Wednesday, January 23rd: 11:00 - 12:30, Room 7 - Speakers' corner

Selected abstracts original research – Venous/AV access

Moderator:

Stephen Black

Panel:

Rick de Graaf, Sebastian Sixt
1. 11:00 - 11:05
  
  Endovascular management of iliac vein compression syndrome: a prospective case series of 61 patients
2. 11:05 - 11:10
  
  Pelvic congestion syndrome: preliminary experience on embolisation with cyanoacrylate and cross over technique from unilateral approach
3. 11:10 - 11:15
  
  Flebogrif a new minimally invasive mechano-chemical technique for ablation of the great saphenous vein. One center experience – results of 24-month follow-up
4. 11:15 - 11:20
  
  Midterm result of tunneled catheter placement in hemodialysis patients with central venous stenosis or occlusion
5. 11:20 - 11:25
  
  Vena cava filter deployment prior to percutaneous endovenous therapy for proximal lower limb deep venous thrombosis: Should we routinely practice?
6. 11:25 - 11:30
  
  Fate of groin after radiofrequency ablation of varicose vein
7. 11:30 - 11:35
  
  Iliac vein obstruction in chronic venous disease: efficacy of computed tomography venography when compared to intravascular ultrasound
8. 11:35 - 11:40
  
  Mid-term improvement of persistent headaches in patients with multiple sclerosis undergoing balloon venoplasty of internal jugular veins
9. 11:40 - 11:45
  
  The use of ultrasound accelerated thrombolysis vs. catheter guided thrombolysis for the treatment of DVT of lower extremities
10. 11:45 - 11:50
  
  Covered stents are an endovascular option for hemodialysis-related venous occlusive disease
11. 11:50 - 11:55
  
  The early and mid-term results of endovascular treatment for central venous obstruction in hemodialysis patients
12. 11:55 - 12:00
  
  Hemodialysis access induced distal ischemia; effectiveness of different types of revisional surgeries
13. 12:00 - 12:05
  
  Removal of 16-year old permanent trapease IVC Filter: presentation + review of the literature
14. 12:05 - 12:30
  
  Discussion
Wednesday, January 23rd: 12:30 - 13:30, Room 7 - Speakers' corner

Selected abstracts original research – Carotid/visceral/renal

Moderator:

Stefan Müller-Hülsbeck

Panel:

Steffen Basche
1. 12:30 - 12:35
  
  Outcome of carotid artery stenting in patient with combined carotid and coronary artery disease
2. 12:35 - 12:40
  
  Endovascular reconstruction of extracranial traumatic internal carotid artery dissections: A systematic review
3. 12:40 - 12:45
  
  12-year experience of stent treatment of extracranial carotid stenosis (ECE)
4. 12:45 - 12:50
  
  1-year result of stent graft for carotid artery pseudo-aneurysm in Behcet’s disease patients
5. 12:50 - 12:55
  
  Modified anchor technique for stenting of main arteries of the head ostial stenosis
6. 12:55 - 13:00
  
  Monitoring of hemoperfusion of the brain and control of the absence of embolic ischemic foci according to CT perfusion and MRI in endovascular treatment of patients with multifocal stenotic and occlusive lesions of the cerebral artery
7. 13:00 - 13:05
  
  Carotid surgery in patients with contralateral occlusion: no shunt or endovascular
8. 13:05 - 13:10
  
  Management strategy for symptomatic spontaneous isolated dissection of the superior mesenteric artery: A proposal algorithm
9. 13:10 - 13:15
  
  Single center experience with open and endovascular treatment of the Nutcracker syndrome
10. 13:15 - 13:30
  
  Discussion
Wednesday, January 23rd: 13:30 - 15:00, Room 7 - Speakers' corner

Selected abstracts original research – PVD/iliac

Moderator:

Sigrid Nikol

Panel:

Fabrizio Fanelli
1. 13:30 - 13:35
  
  Peripheral vascular disease in women in Argentina: more serious, under-recognised and undertreated
2. 13:35 - 13:40
  
  Impact of secondary prevention on outcome in patients with peripheral artery disease
3. 13:40 - 13:45
  
  Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. From PREDICT study
4. 13:45 - 13:50
  
  Digital variance angiography as a paradigm shift in carbon-dioxide angiography
5. 13:50 - 13:55
  
  4F peripheral arterial interventions via percutaneous brachial artery access
6. 13:55 - 14:00
  
  Multicentric registry of lower limbs angioplasty in Argentina: Initial results
7. 14:00 - 14:05
  
  Surgical technique of Impella 5.0 Ventricular Assist Device Transaxillary Artery Placement
8. 14:05 - 14:10
  
  Endovascular treatment of arterial injuries with Bentleys BeGraft stent-graft system: Preliminary results
9. 14:10 - 14:15
  
  Meta-analysis of direct surgical vs. endovascular revascularisation for aorto-iliac occlusive disease
10. 14:15 - 14:20
  
  Hybrid procedure in patients with critical ischemia with common femoral artery and aortoiliac occlusive disease for TASC II
11. 14:20 - 14:25
  
  Hybrid procedure in comparison with aorto femoral shunting in patients with lesions of the iliac arteries (TASC C, D) and hemodynamically significant lesions of the common femoral artery: Final results
12. 14:25 - 14:30
  
  Fusion imaging reduces radiation and contrast medium exposure during endovascular revascularisation of iliac steno-occlusive disease
13. 14:30 - 14:35
  
  An Australian multicenter experience with the Endologix AFX unibody stent graft for the treatment of aortoiliac occlusive disease
14. 14:35 - 14:40
  
  Results from a multicenter study of transradial iliac artery stenting in Japan
15. 14:40 - 14:45
  
  Endovascular approach in terminal aorta occlusion: how and when
16. 14:45 - 14:50
  
  An endovascular solution for a troubling orthopedic complication: Rapid coil embolization of a profunda branch laceration during a complex femoral shaft fracture repair
17. 14:50 - 14:55
  
  Is exercise always good for you? An arterial thrombosis due to excessive crossfit exercise
18. 14:55 - 15:00
  
  Safety and efficacy of the use of covered stent for the treatment of iliofemoral disease
Wednesday, January 23rd: 15:00 - 16:30, Room 7 - Speakers' corner

Selected abstracts original research – SFA/popliteal/BTK

Moderator:

Iris Baumgartner-Peuker

Panel:

Ralf Langhoff, Lawrence Garcia
1. 15:00 - 15:05
  
  The periodical difference of SFA intervention from MK3 study
2. 15:05 - 15:10
  
  Endovascular treatment with the Phoenix atherectomy system in patients with chronic limb ischemia. A series of 74 consecutive patients
3. 15:10 - 15:15
  
  Can vessel preparation minimize residual stenosis and improve outcomes?
4. 15:15 - 15:20
  
  Drug-eluting stent implantation vs. bypass surgery for in-stent occlusion after femoropopliteal stenting
5. 15:20 - 15:25
  
  Increased incidence of acute limb ischemia in patients treated with femoropopliteal stenting vs. atherectomy or angioplasty: A comparison of 823 consecutive femoropopliteal interventions
6. 15:25 - 15:30
  
  Drug coating balloon use for symptomatic femoropopliteal arterial disease treatment
7. 15:30 - 15:35
  
  Impact of tibial runoff on outcomes of endovascular treatment for femoropopliteal atherosclerotic lesions
8. 15:35 - 15:40
  
  1-year outcome of DCB for long femoropopliteal artery disease in real-world practice from a single center in China
9. 15:40 - 15:45
  
  Angiographic classification of popliteal artery morphology in relation to patients phenotype in symptomatic peripheral artery disease (PAD)
10. 15:45 - 15:50
  
  Popliteal artery angioplasty for CTO with vs. without distal landing zone
11. 15:50 - 15:55
  
  Could IVUS guided intervention for below the knee artery improve the clinical outcomes?
12. 15:55 - 16:00
  
  IVUS guided real intraluminal approach improve clinical outcome of SFA-CTO compared with conventional intraluminal approach
13. 16:00 - 16:05
  
  Safety and efficacy of the use of sirolimus eluting coronary self expanding system for the treatment of iliofemoral disease
14. 16:05 - 16:10
  
  How to maximize the effect of Zilver PTX? - Three year follow up data of Zillver PTX in our hospital
15. 16:10 - 16:30
  
  Discussion
Thursday, January 24th: 9:30 - 11:30, Room 7 - Speakers' corner

Challenging cases and complications – EVAR general/infrarenal

Moderator:

Frans Moll

Panel:

Spiridon Botsios, Frank Vermassen
1. 09:30 - 09:35
  
  Could EVAR be done without preoperative Duplex, CT or IVUS in patient with border line renal function?
2. 09:35 - 09:40
  
  Direct ultrasound guided anterior puncture of the aneurysmal sac for embolization of enlarging Internal iliac artery aneurysm in association with a Type II endoleak
3. 09:40 - 09:45
  
  CHEVAS technique: challenging case of a pseudoaneurysm rupture in the proximal abdominal aortic anastomosis
4. 09:45 - 09:50
  
  A case of trapped VIABAHN string in the AFX skeleton successfully bailed out using laparoscopic scissors
5. 09:50 - 09:55
  
  Endovascular treatment of hypogastric artery aneurysm using an internal branch device
6. 09:55 - 10:00
  
  Exclusion of a large ruptured femoral artery aneurysm with two endoprothesis outside the “instructions for use”
7. 10:00 - 10:05
  
  Indication for inferior mesenteric artery chimney procedure: Synchronous AAA, mesenteric ischemia, and aortoiliac occlusive disease
8. 10:05 - 10:10
  
  Endovascular treatment, in addition to anticoagulation, is recommended in patients with symptomatic mobile intraaortic thrombus
9. 10:10 - 10:15
  
  Long-term complications after an endovascular repair of a polianeurysmatic dystrophy
10. 10:15 - 10:20
  
  Uncommon complications leading to conversion after EVAR
11. 10:20 - 10:25
  
  Parallel stent graft technique to rescue an accidental coverage of superior mesenteric artery during endovascular treatment of a dissecting AAA
12. 10:25 - 10:30
  
  Management of uncommon type of endoleak after EVAR
13. 10:30 - 10:35
  
  Transcaval sac puncture – the first choice in the treatment of Type II endoleaks with aortic sac enlargement
14. 10:35 - 10:40
  
  Graft infection with a large retroperitoneal abscess after EVAR, a case report
15. 10:40 - 10:45
  
  Patient-tailored strategies for hostile iliac artery during EVAR
16. 10:45 - 10:50
  
  Failure to regress: A new metric for aneurysm surveillance following EVAR
17. 10:50 - 10:55
  
  Unusual case of rhabdomyolysis after endovascular aneurysm repair
18. 10:55 - 11:00
  
  Endovascular management of AAA post Aorto Bi femoral bypass graft
19. 11:00 - 11:05
  
  Coarctation of the abdominal aorta: endovascular treatment with bare CP stent
20. 11:05 - 11:10
  
  Combined EVAR and a covered stent in the iliac veins for the treatment of right common iliac artery aneurysm with arteriovenous fistula to the right common iliac vein
21. 11:10 - 11:15
  
  Endovascular repair of abdominal aortic aneurysms associated to total iliac axis occlusion using bifurcated endografts
22. 11:15 - 11:20
  
  Late development of severe periaortic inflammation and retroperitoneal fibrosis (Ormonds disease) after routine-EVAR resulting in hydronephrosis and renal failure – case report and literature review
23. 11:20 - 11:25
  
  Fusion Image Laser Fenestration In Situ (FIL&FIS) for endovascular repair of Type 1A endoleak
24. 11:25 - 11:30
  
  A fuming case: CHEVAR for impending juxtarenal aortic aneurysm rupture
Thursday, January 24th: 12:30 - 13:45, Room 7 - Speakers' corner

Innovation forum – EVAR

Moderator:

Wei Guo

Panel:

Nilo Mosquera
1. 12:30 - 12:35
  
  Extend Petticoat strategy in difussed (DeBakey III) aortic dissection Type B. New strategy to stop aneurysmatic degeneration
2. 12:35 - 12:40
  
  Bikini stents for anatomically challenging cases of sacular aneurysms
3. 12:40 - 12:45
  
  A new fully automated imaging software to characterize abdominal aortic aneurysms properties
4. 12:45 - 12:50
  
  A template to create physician modified stent-graft: 3D printed aortic replica
5. 12:50 - 12:55
  
  Matching analysis between classic and arch first technique in frozen elephant trunk for aortic arch repair
6. 12:55 - 13:00
  
  The AORTIST cloud platform: a deep learning based clinical decision support system for thoracic endovascular aortic repair (TEVAR)
7. 13:00 - 13:05
  
  Real time evaluation of flow patterns of AAA depending on intra-aneurysmal thrombosis using AneurysmFlow
8. 13:05 - 13:10
  
  In situ laser-assisted fenestration of aortic stentgraft (ISLAS) using CTA image fusion guidance for endovascular repair of complex aortic aneurysm: safety, feasibility, and effectiveness
9. 13:10 - 13:15
  
  Augmented reality to facilitate endovascular aortic repair
10. 13:15 - 13:20
  
  The use of CO2-angiography and vessel navigator technology decreases iodinated contrast medium amount during FEVAR
11. 13:20 - 13:25
  
  Preliminary results of expanding indications for treatment with standard EVAR in patients with challenging anatomies, a multi-centric prospective evaluation (EXTREME) study
12. 13:25 - 13:30
  
  3D aortic model to facilitate urgent endovascular treatment of para-visceral aortic pathologies using physician-modified stent-grafts
13. 13:30 - 13:35
  
  The FDA limitation: Innovative solutions for treating complex aortic pathology in the United States
14. 13:35 - 13:45
  
  Discussion

Scientific Posters

13 events

Tuesday, January 22nd: 8:00 - 18:00, Scientific Posters

Electronic posters will be displayed from 08:00 – 18:00 in front of Main arena 1
Tuesday, January 22nd: 13:00 - 14:45, Scientific Posters

Challenging cases: Iliac, venous

Juror:

Houman Jalaie, Stephen Black
1. 13:00 - 13:05
  
  The challenging procedure of complex AIOD with newly iliac covered stent
2. 13:05 - 13:10
  
  Successful endovascular treatment of a rigid patient with Leriche syndrome
3. 13:10 - 13:15
  
  Successful hybrid revascularisation in TASC D AIOD aortic occlusion plus bilateral iliac artery occlusion by applying CERAB concept
4. 13:15 - 13:20
  
  Primary stenting for chronically occluded abdominal aorta in a high-risk patient
5. 13:20 - 13:25
  
  Open repair of asymtomatic iliac pseudoaneurysm: a late complication after of the implantation of common iliac artery stent
6. 13:25 - 13:30
  
  “Crush Stenting” a new approach to treat occluded iliac stent
7. 13:30 - 13:35
  
  Endovascular treatment of a iatrogenic iliac arteriovenous fistula
8. 13:35 - 13:40
  
  Compression of the left common iliac vein by the right common iliac artery at the end of gestation
9. 13:40 - 13:45
  
  Successful single session treatment of massive left-side iliofemoral deep vein thrombosis in May-Thurner syndrome
10. 13:45 - 13:50
  
  Popliteal vein compression .... is it a main cause of DVT?
11. 13:50 - 13:55
  
  Stenosis of the brachiocephalic vein and percutaneous thoracic thrombectomy with Thrombectomy system– case report
12. 13:55 - 14:00
  
  Giant femoral artery pseudoaneurysm associated with arteriovenous fistula following shotgun injury with multiple complications
13. 14:00 - 14:05
  
  Endovascular recanalisation of extensive chronic total femoro-ilio-caval occlusion in a persistent bilateral venous ulcers
14. 14:05 - 14:10
  
  Combined role of endovenous laser ablation, inj.ethanol embolisation & foam sclerotherapy in the treatment of congenital venous malformations (K-T Syndrome) cases
15. 14:10 - 14:15
  
  Early results of venous stenting when there are no healthy landing zones in thrombophilic patient
16. 14:15 - 14:20
  
  May Thurner syndrome and left labial varices
17. 14:20 - 14:25
  
  The role of 3D venous angiography and IVUS in diagnostic and treatment decision in May Thurner syndrome
18. 14:25 - 14:30
  
  Sudden rapid progressive venous gangrene in upper limb with 2 years well functioning AV access
19. 14:30 - 14:35
  
  Endovascular treatment of post thrombotic syndrome in the left inferior vena cava
20. 14:35 - 14:40
  
  A successful intervention for venous thrombosis and pulmonary embolization with anti-thrombin deficiency
21. 14:40 - 14:45
  
  Iliofemoral venous stenting for patients with chronic post-thrombotic venous occlusive disease
Tuesday, January 22nd: 15:00 - 16:35, Scientific Posters

Original research: AV-access, iliac, venous, and miscellaneous

Juror:

Robert Jones, Rick de Graaf
1. 15:00 - 15:05
  
  Safety and efficacy of covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for complex aortoiliac occlusive disease: a single center experience
2. 15:05 - 15:10
  
  Time differentiation based image enhancement algorithms for kinetic imaging
3. 15:10 - 15:15
  
  6-month result from a double-blinded randomised control trial for DCB vs. plain balloon angioplasty for dysfunctional vascular access

Notice

LINC 2019 programme

LINC 2019 programme

Room 1 - Main Arena 1

Symposium: Keep on walking: Steps towards successfull PAD treatment

Step by step SFA/pop treatment algorithm

Step by step selection algorithm and clinical decision making through OCT technology

Live case transmission from Leipzig

Supera CFA VMI 1-year follow-up results

Supera in AVF management and 1-year outcomes

Supera in popliteal aneurysm, proof of concept, and clinical outcomes

Live case transmission from Leipzig

Symposium: See clearly, treat optimally: image guided therapy on the rise

Introduction and learning objectives

Next generation pan-vascular suite: optimizing patient management and outcomes

Perfusion angiography for optimizing planning and treatment of diabetic foot

BTK recorded case presentation

Role of IVUS within a “treat optimally” algorithm of care

Innovations at the forefront: a glance at the future of image guided therapy

Live case transmission from Leipzig

Q&A and conclusion

Long-term safety of drug-eluting technologies in the leg – recent findings, controversies, and future outlook

Risk of death following application of Paclitaxel-coated balloons and stents in the femoropopliteal artery – findings from a metaanalysis of RCTs

A look into the methods: merits and limits of meta-analysis

Toxicological aspects and safety profile of Paclitaxel

Event adjudication in clinical trials: how does it work?

PATIENT LEVEL DATA FROM MAJOR CLINICAL TRIAL PROGRAMMES WITH DRUG-ELUTING DEVICES

DCBs over the long-term: Are they safe for our PAD patients? Insights from the In.Pact DCB programme

Long-term safety data of the Lutonix DCB formulation

Long-term safety data from the Stellarex DCB programme

Long-term safety information on Paclitaxel eluting stents – insights from the Zilver PTX programme

Patient safety in the Eluvia-DES and Ranger DCB programme

How to proceed to generate more evidence on patient safety with drug-eluting devices

Podium discussion

“To stent or not to stent?” – Latest data on stentless and stent-based treatment approaches for femoropopliteal lesions

FOCUS ON NEW DATA ON DRUG-COATED BALLOONS

First time data release: Randomized trial of DCB vs. PTA: Final 3-year clinical outcomes from IN.PACT Japan

First time data release: Insights from the IN.PACT global study 3-year data: Does lesion complexity affect results?

First time data release: Global diabetic analyses of all Lutonix DCB SFA combined trials

First time data release: COMPARE-Pilot RCT: 2-year results of a randomized comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions

First time data release: IN.PACT Global study 3-year outcomes for stented vs. non-stented lesions

First time data release: Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries: 24-months results of the BIOLUX P-III full cohort

DCB in severe Calcium: Core-laboratory analysis and perspectives from the ILLUMENATE trial series

Stellarex in real world: Interim look from the SAVER registry

FOCUS ON NEW DATA ON DRUG-ELUTING STENTS AND DCB/IMPLANT COMBINATIONS

First time data release: Final 12-months results of the Zilverpass-RCT of Zilver PTX vs. bypass

TOBA II Trial (Lutonix or POBA + Tack) – 1-year results

First time data release: Diabetic patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents

First time data release: Japanese patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents

First time data release: Zilver PTX Japan 5-year results for paclitaxel-eluting stent treatment of femoropopliteal artery disease

The Illumina FIH study with a next generation DES – 12-months results

Discussion and conclusion

Symposium: Strategies and innovative solutions for success in complex peripheral arterial disease

Endovascular lessons learned in the last decade: what are the remaining challenges?

Live case transmission from Leipzig

Long lesions: primary stenting or DCB first?

Calcium: The Achilles heel of endovascular? Scaffold or remove before drug delivery?

Live case transmission from New York

Dissections: prevent, minimize, or repair

Discussion and conclusion

Symposium: Virtues of VIRTUS: Exploring implications for clinical practice

Welcome and introduction

VIRTUS: Trial design and primary endpoint results

Panel discussion and questions

Complexities of chronic venous disease

Imaging, its central role in planning and guiding intervention

VICI VENOUS STENT: Design attributes & patient outcome

Live case transmission from Galway

Panel discussion and questions

Advanced solutions for complex femoral lesions and critical limb ischemia

True minimally invasive access strategies for complex peripheral interventions

Live case transmission from Leipzig

First time data release: Can Legflow® improve treatment of long femoropopliteal lesions: the REFLOW outcomes

First time data release: Total IN.PACT™ 1-year results: Complex lesion outcomes from the IN.PACT study series

IN.PACT Admiral DCB: a look at long lesion outcomes across trials

From research to practice: how does atherectomy fit in my treatment algorithm

Live case transmission from New York

REALITY: Initial experience

Phoenix atherectomy: technique and real-world evidence

Optimizing the treatment of BTK vessels in critical limb ischemia: Focus on new trials, drug-eluting technologies, and new implants